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ABSTRACT 
MODULATION OF HOST INNATE IMMUNE CELLS BY YERSINIA PESTIS TO CREATE A 
PERMISSIVE ENVIRONMENT FOR REPLICATION 
Amanda R. Pulsifer 
March 13, 2020 
Yersinia pestis has gained widespread infamy due to the historic outbreak during the middle ages, 
referred to as The Black Death. Infection with Y. pestis typically begins with deposition of Y. pestis 
into the dermis (bubonic plague) or respiratory tract (pneumonic plague). Tissue resident 
macrophages are the first innate immune cell encountered by Y. pestis. Macrophages are likely a 
way for Y. pestis to avoid neutrophils early in infection when the neutrophil neutralizing Type Three 
Secretion System is not expressed. This work focuses on which Rab host proteins are manipulated 
by Y. pestis, and how neutrophils are forced to remain silent when all alarms and the arsenal they 
possess should be triggered. Through an RNAi screen 13 of 45 screened Rab proteins were found 
to be important for intracellular Y. pestis survival. The Rab proteins were prioritized based on the 
impact gene knockdown had on Y. pestis intracellular survival. Overexpressed Rab2b and Rab20 
co-localized to the YCV, while overexpressed Rab13 did not. Indicating Rab13 may regulate Y. 
pestis intracellular survival in a contact independent manner. Survival within macrophages likely 
provides Y. pestis time to express the type three secretion system. Using deletion and addition 
mutants, I found that Y. pestis uses the type three secretion system effectors, YopE, YopH, YopJ, 
and YpkA to inhibit neutrophil degranulation, in addition to inhibiting LTB4 production in human 
neutrophils also by YopT. Unlike human neutrophils, LTB4 is not produced in response to Y. pestis 
in mouse neutrophils or macrophages and the zinc binding protein, calprotectin is released in vivo, 
but not by human neutrophils. Together, the Rab data and neutrophil exocytic responses contribute 
to our understanding of how Y. pestis manipulates host phagocytic cells to create a permissive 
environment in which to survive and replicate.  
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Plague: Transmission, disease progression, and epidemiology. 
 Yersinia pestis is an adept pathogen with a well-documented history of causing disease in 
human populations, manifesting as the disease known as plague. Infection with Y. pestis results in 
a variety of signs and symptoms contingent upon the route of inoculation. Y. pestis is a vector borne 
pathogen, passing from rodents to accidental human hosts through the bite of infected fleas [1]. 
The ability of Y. pestis to be transmitted by an insect vector was acquired after divergence from the 
enteric pathogens Y. enterocolitica and Y. pseudotuberculosis [2]. Flu-like symptoms are the first 
warning signs of plague, with body aches, fever, chills, and other symptoms [1].  
When Y. pestis is transmitted through flea bite into the skin, the form of plague that arises 
is referred to as bubonic plague. Bubonic plague is approximately 30-60% lethal in infected 
individuals without antibiotic treatment, with an infectious dose ranging from as little as one to one 
hundred bacteria [1]. As Y. pestis disseminates from the site of inoculation and colonizes the 
draining lymph node, the hallmark buboes begin to form, from which the name bubonic plague is 
derived, as Y. pestis proliferates in the lymph node to high numbers [3, 4].  
Septicemic plague occurs when Y. pestis enters the blood upon dissemination, or direct 
inoculation of Y. pestis into the blood during flea feeding. Upon entering the blood, a required part 
of the transmission process, Y. pestis spreads throughout the host quickly colonizing major areas 
of blood filtration such as the spleen, liver and lungs [5, 6]. Septicemic plague is highly lethal, killing 
~100% of untreated patients within 72 hours [1]. As the bacteria overtake the host, tissues in the 
extremities begin to undergo necrosis, causing a visible blackening of the tissues.  
There are two classifications of pneumonic plague, which are differentiated by the way in 
which Y. pestis enters the lungs. Primary pneumonic plague arises when the bacteria enter the 
lungs from an exogenous source, such as inhaling aerosolized droplets containing Y. pestis. 
Secondary pneumonic plague arises from Y. pestis entering the lungs via the blood, subsequent to 
either disseminated bubonic or primary septicemic infection. Similar to septicemic plague, 
pneumonic plague is ~100% lethal within 72 hours without antibiotic administration [1]. Pneumonic 
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plague can also result in human to human spread, through aerosols generated by coughs and 
sneezes. 
Three Y. pestis pandemics have been classified. The first pandemic is referred to as the 
Plague of Justinian, and began in the 6th century and lasted approximately 200 years [7]. The 14th 
century (Middle Ages) saw the rise of one of the most noted plague outbreak events, referred to as 
the Black Death. Plague contributed to extensive loss of human life as the pandemic swept through 
western Asia and Europe and flare up outbreaks continued well into the 1600s [8]. Studies have 
isolated Y. pestis DNA from the teeth of individuals buried in mass graves who died during this time 
period, confirming Y. pestis caused was the cause of the human casualties [9]. Many estimate the 
European population was reduced by 1/4th to 1/3rd during the Black Death [10]. The third pandemic 
began around 1896 and is still ongoing today. Cases of plague sporadically occur around the globe 
as spillover events due to Y. pestis now being endemic in rodent populations. 
How Y. pestis has spread across the globe has not been fully elucidated and is the topic 
of many studies. China is believed to be the source from whence all three pandemics originated 
[11]. For the Plague of Justinian and the Black Death it is thought that the Silk Road was the route 
from which Y. pestis spread into Europe [12]. The Silk Road was the main trading route for the time 
and was a thoroughfare for transporting goods through and out of China. The Silk Road connected 
China to eastern Asia, and eventually Europe, via the Mediterranean. Incidences of plague 
outbreaks were reported to have occurred along the Silk Road route, supporting the idea that the 
Silk Road was likely the pathway for introduction of plague into Europe.  
A direct land route was not possible for movement of Y. pestis into the Americas. However, 
ships laden with goods from China arrived in the ports of California, and thus introduced plague 
into the Americas [13]. From the Californian ports, Y. pestis radiated out into the native rodent 
populations of western North America, finding a new reservoir in prairie dogs, squirrels, and other 
American rodents [14]. Y. pestis has become a blight on two American animal populations, 
decimating prairie dog colonies and spilling over into the black footed ferret population, whom pray 
upon prairie dogs [15]. Y. pestis not only kills susceptible black footed ferrets, but those fortunate 
4 
 
enough to avoid infection, face ultimate demise when prairie dog populations, the sole food source 
of black footed ferrets, dwindle. Conservation efforts to re-establish the endangered black footed 
ferret populations have been hindered by Y. pestis outbreaks in prairie dog colonies [16]. A number 
of spill over events from rodents into human populations occur each year in the American west, 
acting as a detriment not only to rodent populations and black footed ferret populations, but humans 
as well [17]. 
While North America records several human plague cases yearly, Madagascar usually 
records the most human plague cases each year [18]. Wild rodents on the island harbor Y. pestis 
and spill over events occur yearly [19]. The worst outbreak of plague in recent years was from the 
Fall of 2017, when more than 2,000 cases of plague were reported [20, 21]. The disease was first 
transmitted to humans through fleas, but human to human transmission via pneumonic plague was 
the main driver of this outbreak [20]. Early cases were first recorded in rural areas, but as humans 
traveled, cases began to appear in the capital city of Antananarivo [20, 21]. With pneumonic plague 
cases in the crowded capital city, the number of cases increased until mechanisms to prevent the 
spread were implemented. The 2017 Madagascar outbreak is fresh in our memory, but outbreaks 
in India, China and South America also occur annually [22, 23]. Climate change has the potential 
to change reservoir host habitats that could increase potential human spill over events. Lack of an 
approved vaccine for human use, continues to leave human populations around the globe 
vulnerable to outbreaks of plague.  
Y. pestis as a Bioweapon. 
Y. pestis has unfortunately also been used as a biological weapon [24]. During the War of 
Kaffa, plague infected corpses were tossed over the walls of the besieged city by the invading 
Tartar army in the hopes that the disease would be transmitted to inhabitants [25]. A more recent 
use was during World War II, when Japan performed research on prisoners of war using Y. pestis 
to study how quickly people die and how it could be used to against foreign nations. Additionally, 
Unit 731 of Japan made possible the utilization of Y. pestis as a “biological bomb” by dropping rice 
mixed with Y. pestis infected fleas over China [25]. Due to study and use of Y. pestis as a biological 
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weapon during WWII, it has been estimated that several thousand individuals were infected, with 
recurrent outbreaks of plague in subsequent years [26]. Japan was not the only modern country to 
weaponize Y. pestis. During the cold war, both Russia and the United States had active programs 
working to create aerosolized Y. pestis to target the opposition. In addition, Russia was also 
pursuing ways in which to increase the lethality of Y. pestis infection by attempting to combine Y. 
pestis with toxins or viruses. The plan was for the toxins or viruses to release upon treatment with 
antibiotics due to lysis of Y. pestis [25].  
While neither country has active biological weapons programs now, concerns that Y. pestis 
could be used again as a bioweapon still remain. Counter-terrorism has been a top priority for the 
United States government, but the efficacy of such measures has not been assured. Due to the 
history of Y. pestis use as a biological weapon, combined with transmission through aerosols and 
high mortality rates, the United States designates Y. pestis as a Tier 1, Category A Select Agent. 
Due to the select agent classification restricts have been implemented for working with Y. pestis. 
To ensure proper containment of the agent, Y. pestis must be worked with in specialized facilities 
designed with engineering controls and personal protective equipment to prevent exposure to the 
pathogen. Additionally, precautions are taken to ensure proper handling and storage occurs to 
mitigate the potential release or misuse of the agent from occurring. 
Divergence from ancestral strains. 
Although infection with Y. pestis is one of the most deadly and rapidly progressing 
infections a human can contract, the closely related enteric pathogens Yersinia enterocolitica and 
Yersinia pseudotuberculosis are not as adept at killing humans as Y. pestis is [1, 27-29]. Both Y. 
pseudotuberculosis and Y. enterocolitica are food borne pathogens that cause a self-limiting 
gastroenteritis [28, 29]. After ingesting either of these enteric pathogens, they cross the intestinal 
barrier and enter the intestinal lymph nodes (mesenteric) [30, 31]. The diseases caused by the 
enteric Yersinia are very similar due to divergence from a common ancestor and possession of 
many common virulence factors [27, 32, 33]. From Y. pseudotuberculosis, Y. pestis subsequently 
diverged, which included loss of two virulence factors important for enteric Yersinia pathogenesis 
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(Invasin and YadA), and acquisition of two plasmids encoding murine toxin and the plasminogen 
activator (Pla) [2]. The divergence uniquely adapted Y. pestis to a vector borne lifestyle, while 
enhancing the ability of Y. pestis to disseminate and evade host innate immune responses.  
Y. pestis infection - avoiding innate immune system mediated clearance. 
Y. pestis maintains a hallmark non-inflammatory host environment up to 24 h post-
infection. The innate immune system subsequently responds by causing massive expression of 
antimicrobial products and cytokines, referred to as a cytokine storm [34-36]. By the time an 
inflammatory response is mounted, Y. pestis has enacted a defense mechanism capable of 
neutralizing innate immune cells. Ultimately, necrosis of host tissues occurs without impacting Y. 
pestis replication, resulting in death of the host before an adaptive immune response is ever 
mounted [37]. The innate immune system is therefore the primary line of defense against Y. pestis.  
How Y. pestis maintains an early non-inflammatory phase is a question that may hold the 
key to understanding Y. pestis disease progression. Innate immune cells are key to production of 
an inflammatory response to bacteria, and are thus likely being manipulated or subverted by Y. 
pestis to maintain the non-inflammatory phase [38]. From when Y. pestis was first identified as the 
etiological agent of plague, the Y. pestis field has attempted to better understand the ways in which 
Y. pestis interacts with the innate immune system [36, 37, 39]. Using a mouse model of infection, 
Y. pestis has been shown to interact primarily with neutrophils, macrophages, and to some extent 
with dendritic cells very early during infection, but these cells are not able to clear the infection [40-
43]. Due to the ability of Y. pestis to avoid clearance, research efforts have focused on 
understanding how Y. pestis interacts and avoids clearance by these innate immune cells [36, 41]. 
Possession of several virulence factors and modulation of key surface exposed antigens have 
allowed Y. pestis to subvert and directly combat innate immune responses to establish disease [33, 
35, 44-46].  
Changes in LPS allow evasion of inflammation. 
Toll like receptors (TLRs) are members of the host pattern recognition receptors (PRRs) 
that rapidly identify molecules produced by pathogens (referred to as pathogen-associated 
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molecular patterns or PAMPS) leading to activation of the immune response [47]. 
Lipopolysaccharide (LPS) produced by Gram negative bacteria is typically recognized by TLR4 
leading to activation of the NF-kB pathway triggering inflammatory cytokine and lipid mediator 
responses to coordinate multicellular responses to the infection [48]. However, all three pathogenic 
Yersinia are able to switch the LPS they display from a hexa-acylated TLR4-stimulatory form, to a 
tetra-acylated TLR4-non-stimulatory form with variability in lipid A structure [49]. Switching to the 
tetra-acylated non-stimulatory form allows for evasion of the innate immune response, 
demonstrated by data showing inhibition of LPS modification results in attenuation and clearance 
of Y. pestis due to ligation and signaling through a TLR4/MD2/ MyD88 dependent pathway [48, 50, 
51]. Y. pestis also lacks O-antigen, leaving the LPS core components exposed [49]. A recent study 
demonstrated this modification to be important for interaction with antigen presenting cells (APCs) 
and specifically for binding of the C-type lectin, CD209b (SIGNR1) to enhance dissemination of Y. 
pestis [52]. 
Ail contributes to complement resistance. 
 The enteric Yersinia have two important adhesins involved in virulence (Invasin and YadA) 
that Y. pestis does not have. A conserved adhesin, shared between all three pathogenic Yersinia, 
and important for virulence, is Ail [53-56]. Ail is an outer membrane protein (OMP) with greatest 
efficacy at 37°C, when the O antigen of LPS is shed from the bacterial surface [57]. Exposure of 
Ail allows the bacterium to bind host C4b binding protein to inactive the complement component 
C3 convertase, protecting Yersinia from the complement cascade [45]. Additionally, Ail also 
enhances adherence and targeting of innate immune cells for Type 3 secretion (see below), thus 
diminishing recruitment of neutrophils and inhibiting inflammation [53, 55].  
The Pla adhesin/protease contributes to dissemination. 
 The plasminogen activating protein (Pla), encoded on the pPCP1 plasmid, was acquired 
by Y. pestis and has been shown to aid in attachment to host cells [33, 58]. Pla not only acts as an 
adhesin, it is also an omptin family of proteases, and has been shown to cleave host complement 
proteins and inhibit the function of plasminogen activator inhibitor -1 (PAI-1) [59]. Inhibition of PAI-
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1 blocks degradation of host extracellular matrix by matrix metalloproteases, limiting the breakdown 
of cellular junctions, and increasing the difficulty for host innate immune cells to infiltrate the site of 
infection and produce a pro-inflammatory response. A recent study by Banerjee et al. found that 
Pla also functions as a facilitator of T3SS targeting of alveolar macrophages, inhibits neutrophil 
infiltration into the lungs, and is important for resisting neutrophil mediated bacterial degradation 
[60, 61]. Together, Ail and Pla enhance targeting of innate immune cells and resist innate immune 
mediated killing of Y. pestis. 
The F1 Capsule protects against phagocytosis. 
In addition to Pla, Y. pestis also expresses a protein capsule called F1 that is not present 
in the enteric Yersinia [62]. F1 is produced by a modified chaperone usher system on the pMT 
plasmid [63, 64]. The F1 capsule is temperature regulated and does not occur in the flea vector 
[65]. Expression of the F1 capsule is induced at 37°C upon transmission into the mammalian host. 
The F1 capsule blocks interactions with phagocytic cell receptors to contribute to inhibition of 
phagocytosis and protects the bacterium from antimicrobial peptides [66].  
The Type 3 Secretion System is essential for immune modulation. 
While the F1 capsule contributes to inhibiting uptake of Y. pestis, the Type 3 Secretion 
System (T3SS) encoded by the pCD1 plasmid is the primary virulence factor protecting Y. pestis 
from phagocytes [62]. Bacterial T3SS are molecular syringes that span both the inner and outer 
Gram negative bacterial membranes, as well as the mammalian plasma membrane [67]. Bacterial 
effector proteins are rapidly shuttled across all three membranes in an ATP dependent manner 
through the needle of the T3SS [68]. In addition to inhibiting phagocytosis, numerous studies have 
demonstrated the T3SS inhibits multiple arms of the innate immune responses [35, 36, 69-71]. The 
T3SS delivers seven bacterial Yersinia outer proteins (Yops) into the host cell cytosol (Table 1-1). 
Once inside host cells, these Yop effector proteins directly inhibit specific cellular signaling 
pathways [70]. Three effector proteins (YpkA, YopE, and YopT) target the host proteins Rac, Rho, 
and other actin interacting proteins to directly inhibit cytoskeletal rearrangement, effectively 
inhibiting phagocytosis, motility, and other antimicrobial responses [72-76]. Each of these Yop 
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effector proteins have different enzymatic activity. YpkA is a serine/threonine kinase, while YopE 
is a GTPase activating protein, and YopT is a cysteine protease [72, 74, 76-80]. Furthermore, YopH 
is capable of inhibiting cytoskeletal rearrangement through suppression of focal adhesion complex 
signaling, and also inhibiting calcium flux [73, 81-84]. YopJ targets the mitogen activating protein 
kinase (MAPK) signaling pathway to inhibit activation of nuclear factor κB (NF-κB), which regulates 
transcription of cytokines [71, 85-88] 
Disruption of cytoskeletal rearrangement and MAPK signaling is important to inhibit 
antimicrobial and inflammatory responses, and greatly contributes to the non-inflammatory 
environment associated with plague. However, these activities can be recognized by host cells, 
resulting in activation of the inflammasome pathway and cell death [89, 90]. Innate immune cell 
death due to activation of the inflammasome leads to production of inflammatory cytokines. To 
circumvent inflammasome activation due to disruption of the Rac and MAPK signaling by YopE 
and YopH, Y. pestis also delivers two Yop effector proteins capable of inhibiting inflammasome 
activation (YopM and YopK) [91-96]. Inflammasome activation is inhibited by the leucine rich repeat 
containing YopM through disruption of signaling by caspase-1 IQGAP1, and RSK1 [97-99]. 
Historically, the activity of YopK has been less well known. Previous studies have established that 
YopK acts as a regulator of Yop translocation into host cells, to limit inflammasome activation [92]. 
Recent work has shed further light on the activity of YopK, demonstrating that YopK is important 
for inhibiting guanylate binding protein mediated activation of the inflammasome, triggered by the 
T3SS translocon pore [96, 100]. Together, the seven Ysc T3SS effector proteins cripple innate 
immune cell motility, phagocytosis, and the ability to raise warning signals through activation of the 
inflammasome.  
While required for mammalian infection, the T3SS is not required in the flea and thus 
expression of the T3SS is tightly regulated, with temperature, pH, and cation concentration all 
acting as signals for expression [101, 102]. The primary signal differentiating the flea and 
mammalian host is temperature. As such T3SS is low during growth at temperatures mimicking the 
flea (<26°C) and increases when grown at mammalian temperatures (34-37°C) T3SS expression 
also responds to calcium, magnesium, and iron concentrations [101, 103]. Cations are highly 
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regulated in mammalian tissues, allowing pathogenic bacteria to use them as cues for expressing 
or repressing required virulence factors that are metabolically costly, or have the potential to 
errantly activate host defense mechanisms [104, 105].Importantly, since the T3SS (and other 
virulence factors) are not expressed in the flea, there is a transition period after deposition by flea 
feeding when Y. pestis is highly susceptible to being engulfed by phagocytic cells, such as 
macrophages and neutrophils [106-108]. While Y. pestis engulfed by neutrophils are quickly 
degraded, those bacteria phagocytosed by macrophages can survive and even subsequently 
replicate, eventually lysing the out of the macrophage. [107, 109]. The ability to survive and 
replicate within macrophages, but not within neutrophils, has led to the idea that Y. pestis uses 
macrophages early during infection as a way to subvert clearance by neutrophils. Additionally, 
exploitation of macrophages as a hideout would provide Y. pestis with the opportunity to upregulate 
expression of the T3SS and other virulence factors that allow the bacterium to better, combat 
neutrophil antimicrobial defenses.  
Table 1-1:Yersinia T3SS Effector Proteins 
Effector                 
Y. pestis/Enteric Activity Verified Host Target Cellular Effect 
    Mφ and other cell types Neutrophil   
YpkA/YopO Serine/threonine kinase 
VASP, WASP, 
WIP, Gelsolin, 
Gαq, EVL, 
mDia1, INF2, 
cofilin, RhoA, 
Rac1, and 
Rac2 
  
Inhibition of actin 
cytoskeletal dynamics 
contributing to 
perturbance of 
phagocytosis 
YopE GTPase activating protein 
RhoA, Cdc42, 
Rac2, RhoG   
1. Inhibition of actin 
cytoskeletal dynamics 
contributing to 
perturbance of 
phagocytosis 
        
2. Caspase-1 
inhibition resulting in 
disruption of lL-1β and 
IL-18 maturation event 
YopH Protein tyrosine phosphatase 
FAK, p130cas, 
paxillin, Fyb, 
SKAP-HOM, 
PRAM-1, SLP-
76, Vav, 
PLCγ2, p85, 
 SKAP-
HOM, 
PRAM-1, 
SLP-76 
1. Focal adhesion 
complex disruption 
culminating with 
inhibition of 
phagocytosis 
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Gab1, Gab2, 
Lck, LAT 
        
2. Pro-inflammatory 
cytokine/MCP-1 
inhibition 
        3. Calcium response and ROS inhibition 
        4. Inhibition of PI3K and AKT pathways 
YopJ/YopP Acetyltransferase 
TRAF2, 
TRAF6, IκBα, 
MAPKKKs, 
MAPKks, IKKβ, 
RICK, eIF2α 
 
1. Induces Caspase-1 
and apoptosis 
induction 
  Deubiquitinase     
2. Pro-inflammatory 
cytokine, chemokine, 
and adhesion 
molecule inhibition 
  Cysteine protease      
Yop K   Matrilin-2   1. Regulates Yop Translocation 
        
2. Regulates caspase 
and apoptosis 
activation 
YopM Leucine rich repeat protein 
RSK, PRK, 
Caspase-1, 
IQGAP1 
  
1. Induces anti-
inflammatory cytokine 
production, while 
inhibiting pro-
inflammatory 
        2. Caspase-1 and apoptosis inhibition 
YopT Cysteine protease 
RhoA, Rac1, 
Cdc42, RhoG   1. NFkB inhibition 
        
2. Perturb actin 
cytoskeleton 
* denotes information specific to Y. pestis 
Table adapted from [44] 
Y. pestis creates a replicative niche within macrophages. 
The idea that Y. pestis uses macrophages as a niche for evading neutrophil mediated 
destruction is supported by in vivo data pointing to the importance of macrophages for Y. pestis to 
fully establish an infection to cause disease. Chemical depletion of macrophages causes 
diminished dissemination from draining lymph nodes in a sphingosine-1-phosphate dependent 
manner [110]. The response to Y. pestis infection by macrophages is also important for controlling 
infection. In susceptible mice, it has been shown that the murine macrophages produce a non-
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inflammatory response (M2 phenotype), whereas in mice which are resistant to plague, the 
macrophages create an inflammatory response (M1 phenotype) better able to clear Y. pestis [111, 
112]. Pre-treatment to induce an M1 phenotype in susceptible mice enhances the host response 
and is better at clearing Y. pestis infection [111] The requirement for monocytes/macrophages 
during in vivo infection and the evidence that pre-activated macrophages can better combat Y. 
pestis infection, supports the hypothesis that Y. pestis use naïve macrophages as a shelter while 
anti-host factor expression is upregulated. While the fact that Y. pestis is able to survive and 
replicate within macrophages is well accepted, how Y. pestis is able to subvert natural macrophage 
degradative mechanisms has not been well defined. 
Macrophages are a host innate immune cell tasked with patrolling and controlling invasion 
by microorganisms such as bacteria. Macrophages engulf bacteria and encapsulate it within a 
vacuole termed a phagosome [47]. After engulfment, phagosomes are trafficked to a degradation 
specific pathway where they undergo modifications and fuse with another vesicle termed the 
lysosome [47]. Fusion with lysosomes results in formation of a phagolysosome where invading 
organisms are exposed to acidic conditions in which proteases are activated, resulting in 
degradation and elimination of microorganisms. To direct trafficking of phagosomes through the 
maturation process toward fusion with lysosomes, mammalian cells rely upon Rab GTPases [113, 
114]. Early phagosomes associate with Rab5 and EEA1 [113, 115]. Through the maturation 
process, Rab5 is replaced by Rab7 to become a mature phagosome [113]. Fusion of lysomes with 
the phagosome further modifies the membrane so that Rab7 is lost and Rab9 is gained [113]. In 
addition to directing phagosome maturation, Rab GTPases are also involved in trafficking of other 
membranous vesicles throughout cells [113]. The importance of Rab GTPases in trafficking events 
within eukaryotic cells makes these host proteins the target of many bacterial pathogens. 
Unlike other non-pathogenic bacteria, once phagocytosed, the Y. pestis phagosome does 
not progress through the phagosomal maturation pathway. Instead Y. pestis generates a vacuolar 
compartment termed the Yersinia containing vacuole (YCV) (Figure 1-1). YCVs do not appear to 
acidify over the course of macrophage infection and the pH in the YCV remains between 6.5 and 
7.5. [107-109, 116-118]. Additionally, most YCVs fail to co-localize with Rab7, LAMP-1, and 
13 
 
Cathepsin D, markers of mature phagosomes, and thus appear to avoid fusion with lysosomes 
[117]. Instead, large proportion of YCVs co-localize with Rab1b, 4a, and 11b early during 
biogenesis (Figure 1-1) [118, 119]. Furthermore, recruitment of Rab1b and 4a to the YCV appears 
to be essential to avoid vacuolar acidification. [118, 119]. Recruitment of Rab11b does not appear 
to be required to avoid acidification, but proceeds bacterial replication [119]. Sequestration of 
Rab11b on the YCV by Y. pestis disrupts global cellular recycling and leads to the induction of host 
cell autophagy, which has been linked to Yersinia intracellular replication [120, 121]. Targeting of 
the host autophagy pathway has been postulated to serve as a source of membrane by which 
expansion of the YCV occurs to form a spacious vacuole. [117, 119]. Within the spacious YCV, Y. 
pestis replicates and infected macrophages lyse between 12 and 15 h post infection [122]. To date 
the ability of Y. pestis to generate the YCV and replicate within macrophages has not been 
attributed to the function of a known virulence factor. Importantly, the T3SS is not required for 
intracellular survival. However, stress response genes such as those regulated by PhoPQ and the 
rip operon have been shown to enhance survival but not the biogenesis of the YCV [107, 123-126]. 
Therefore, there is currently a major gap in our understanding of how Y. pestis is able to avoid 
killing by macrophages. 
While there is much still to be defined regarding how Y. pestis survives within 
macrophages, it is known that autophagy is required by Y. pestis for intracellular replication [117]. 
Autophagy is a catabolic mechanism utilized by cells to break down and recycle self or foreign 
structures [127]. When cellular components are damaged, or the cell is undergoing stress, 
autophagy is induced in order to break down the products and make available the liberated 
nutrients for repurposing [127, 128]. Depending on the structure being degraded, autophagy is 
labeled differentially. When mitochondria are degraded, it is referred to as mitophagy, whereas 
when bacteria are the degradative target, it is referred to as xenophagy [129]. Autophagy functions 
by enveloping particles within a membrane bound compartment and a typical marker of autophagy 
is the formation of a double membrane structure [128]. Formation of the membranous compartment 
occurs as a cascade of activation signals, and depending on the type of autophagy, the steps in 
formation of autophagic vacuoles can differ. Generally, ULK1 associates with Beclin1, ATG 
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proteins, and adaptor proteins such as p62 to begin forming the autophagosome [130]. Additional 
ATG proteins further elongation of the membrane by adding phosphatidylethanolamine to LC3-I, 
thus converting it to LC3-II and allowing for closure of the vesicle and sensitivity of the inner 
membrane to lysosomal degradation [131]. Rab proteins, such as Rab11 are important for 
autophagy, as they can direct recycling endosome membranes into the autophagy pathway to 
provide membrane for the autophagy expansion process [130]. To degrade the bacteria, syntaxin 
17 associates with the autophagic membrane to facilitate fusion with lysosomes and create a 
structured termed an autolysosome [131, 132].  
While autophagy is beneficial for eukaryotic cells undergoing stress, induction of autophagy 
is detrimental for bacteria which escape from phagosomes and enter into the host cell cytosol to 
replicate, such as Shigella flexneri or Burkholderia species [133, 134]. However, unlike bacteria 
which enter into the cytosol, those remaining within a vacuole can benefit from induction of 
autophagy, such as Anaplasma phagocytilium and Coxiella burnetti [135-138]. Moreover, for the 
vacuolar pathogen Y. pseudotuberculosis which is closely related to Y. pestis, LC3 is recruited to 
the vacuole and autophagy is important for replication within macrophages [120, 121]. Y. pestis 
has been observed co-localized to the autophagy marker LC3 and within a double membrane 
compartment, suggesting Y. pestis enters into the autophagy pathway and benefits from the 
nutrient liberation process similar to other intravacuolar pathogens [117]. 
RNAi screens to identify host pathways important for intracellular survival. 
Our lab has proposed the hypothesis that Y. pestis targets host signaling pathways to avoid 
phagosome maturation to survive within macrophages. To date, conventional bacterial 
mutagenesis screens have been unable to identify bacterial factors required for YCV biogenesis. 
An alternative strategy to better understand the mechanisms used for YCV biogenesis is to identify 
the host factors required for Y. pestis intracellular survival. In order to better understand how other 
pathogens manipulate host processes, large scale RNA interference (RNAi) high throughput 
screening approaches have been used [139]. Utilization of RNAi has been useful for spotlighting 
the differences in host components required for vacuolar versus cytosolic pathogen survival and 
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replication [139]. Moreover, other RNAi screens with Brucella abortus, Chlamydia trachomatis, and 
Salmonella typhimirium, have aided in better understanding the biological mechanisms these 
pathogens use to overcome degradation and to create a permissive intracellular environment for 
replication [140-144]. We used a similar strategy to identify three Rab GTPases (Rab1b, 4a, and 
11b) as required for survival of Y. pestis within macrophages [118, 119]. These studies highlight 
how targeting the host cell using RNAi can provide a better understanding of the mechanisms used 
by bacteria to survive within host cells.  
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Figure 1-1: Y. pestis survival within macrophages.  
Yersinia pestis is phagocytosed by macrophages, yet is not degraded. Phagosomal maturation and 
fusion with the lysosome does not occur, which is dependent on Rab1b. Instead Y. pestis acquires 
Rab1b, 4a, 11b and markers of autophagosomes early during infection, Rab1b and 4a are lost 
while Rab11b is retained and creates a spacious Yersinia containing vacuole wherein replication 
occurs. Finally Y. pestis lyses out of the infected macrophage between 12 and 18 h post-infection. 
Although it is well understood that Y. pestis is able to survive and replicate within macrophages, 
the precise mechanism of how Y. pestis diverts phagosome maturation from fusion with lysosomes 
remains unknown.  
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Neutrophil antimicrobial defense mechanisms. 
 Macrophages are important for Y. pestis to disseminate and fully establish disease within 
the host [52, 145]. Understanding what host components and pathways are used by Y. pestis to 
traffic within macrophages will improve our understanding of how the lysosomal degradative 
mechanism of macrophages is subverted and Y. pestis creates a niche for replication. Conversely, 
neutrophils are detrimental to the survival of Y. pestis within the host. In pneumonic plague, early 
recruitment of neutrophils to the lungs improves the survival rate of infected mice [146]. While Y. 
pestis is able to survive and replicate within macrophages, Y. pestis is not able to survive and 
replicate within neutrophils as observed for macrophages [147]. Even though macrophages and 
neutrophils are both innate immune cells that are able to destroy microorganisms, the antimicrobial 
mechanisms utilized by the two cell types are different in many ways. 
Neutrophils are one of the most abundant leukocytes in the circulatory system and are vital 
for successful control of infections. Neutrophils comprise nearly 70% of the leukocytes within blood 
and were once thought to be short lived, with a life span of only a few hours, due to the monumental 
effort and toxicity combating the infection entails [148, 149]. However, this perceived 
characterization of neutrophil life cycle is being increasingly refuted by accumulating data pointing 
to neutrophils living longer than previously thought with the proper signals [150, 151]. Neutrophils, 
along with other phagocytic cells such as dendritic cells (DCs) and macrophages, are continually 
surveilling for microbial invaders. Unlike DCs and macrophages, which differentiate and remain 
primarily as tissue resident cells, neutrophils primarily patrol in the blood stream, waiting for signals 
from endothelial, epithelial, or other phagocytic cells to indicate an infection or tissue damage has 
occurred in order to home to the tissues [151]. Upon activation, receptors are displayed on the 
neutrophil membrane to enhance homing abilities and allow for increased attachment to endothelial 
membranes. Increased display of integrins on the endothelium, and receptors/ligands on the 
neutrophil surface, allows neutrophils to slow, bind, and eventually stop in the swiftly moving 
bloodstream [151]. Tightly adhering to the endothelium, neutrophils begin the process of 
transmigration to enter into the underlying epithelial tissue [151].  
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Upon reaching the site of infection, neutrophils employ a multifaceted arsenal to neutralize 
the infection as swiftly as possible. Neutrophils use phagocytosis, release of granule contents into 
the phagosome or extracellular space, release of chromosomal content (neutrophil extracellular 
traps [NETs]), and release of reactive oxygen species (ROS) to negatively impact the survival and 
replication of invading microorganisms [152-157]. Although these mechanisms are detrimental to 
the microorganism, they are also destructive to the neutrophil and other nearby host cells. 
Therefore, neutrophils tightly regulate responses based on the pathogenic potential of the 
microorganism [149].  
Phagocytosis. 
Phagocytosis by neutrophils is a very rapid event, occurring within seconds, compared to 
macrophages which require minutes to complete phagocytosis [158]. Upon phagocytosis of the 
microorganism, neutrophils do not traffic the phagosome in the same way as macrophages. 
Instead, neutrophil phagosomes remain at a neutral pH (~pH 7), and do not fuse with lysosomes 
to degrade microorganisms [158]. Instead, neutrophils rely upon fusion with compartments called 
granules and a potent oxidative burst to kill bacteria [149, 153, 158, 159].  
Phagosome granule fusion and ROS response. 
Of the mechanisms neutrophils possess to combat microbial infections, production of 
reactive oxygen species is one of the most effective yet self-destructive, damaging DNA, RNA, 
lipids, and proteins [160-162]. Therefore, production of ROS is a tightly controlled mechanism that 
relies upon other defensive measures to occur before ROS can be produced [153]. To make ROS, 
neutrophils assemble several subunits to create the catalytically active unit known as the NADPH 
oxidase [163-165]. The subunits are the membrane bound cytochrome b558, which has two 
components, p22phox and gp91phox, and cytosolic p47phox, p40phox, p67phox, and Rac2 [165]. The 
membrane bound cytochrome b558 is stored in neutrophil granules, the phagosome must undergo 
fusion with granules containing cytochrome b558 for the respiratory burst to occur. Inhibition of 
granule fusion results in decreased phagosomal ROS production [153]. Production of ROS is more 
effective at killing invading organisms within phagosomes due to the small area in which it is 
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contained aiding in concentrated exposure. However, some microorganisms cannot be 
phagocytosed [166]. To overcome the inability to phagocytose a microorganism, neutrophils shift 
targeting of toxic antimicrobials away from phagosomal delivery, to extracellular release [155, 167, 
168]. Neutrophils are able to release not only ROS into the extracellular milieu, but granule contents 
as well [167, 168]. 
Degranulation. 
Production of ROS is a potent product that interferes with many different targets within the 
invading organism, and the action of ROS is complemented by the potent antimicrobials packed 
into the granules of neutrophils. Similar to other granulocytes, such as basophils, eosinophils, and 
mast cells, neutrophils form preformed granules during maturation [167]. The granule cargo are 
formed and packaged for rapid release to respond to a stimulus as quickly as possible. Granules 
are not homogeneous and there are four different types of granules formed by neutrophils, with 
additional subtypes (Figure 1-2) [167]. There is a hierarchical order in which the granules are 
formed and also in how they are released [167]. While many studies have focused on 
understanding how these four types of granules are differentially regulated for release, the exact 
mechanisms are still under investigation [148, 169].  
Primary (Azurophilic) granules. 
The first granule to form, yet the last to be released, are primary granules also known as 
azurophilic granules [167]. The name azurophilic granule comes from the azurocidin contained 
within, which acts as a chemoattractant and increases vascular permeability [167]. Azurophilic 
granules contain the most potent antimicrobials formed by neutrophils such as lysozyme, 
defensins, bactericidal/permeability increasing protein (BPI), and myeloperoxidase (MPO) [167]. 
While most of the antimicrobial peptides function to directly interact with microorganism 
membranes, MPO reacts with H2O2 produced by NADPH oxidase to cause additional toxicity 
through formation of hypochlorous acid, in addition to others [167]. The toxicity produced by 
azurophilic granule components can cause significant collateral damage to surrounding host tissue. 
Therefore, release is tightly regulated and requires additional stimulus for release than for the other 
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granules. Azurophilic granules are the final granule to be released, as they are held for direct 
interaction with microorganisms.  
Secondary (Specific) granules. 
Through the process of myelopoiesis, the second granule type to be formed are secondary 
granules, otherwise termed specific granules [167]. Specific granules have a duel role, as they are 
important for direct combat with microorganisms, due to the antimicrobials they contain, while also 
functioning for neutrophil movement across cell barriers via breakdown of extracellular matrix [167]. 
The antimicrobials within specific granules include; natural resistance- associate macrophage 
protein 1 (Nramp-1), lactoferrin, and neutrophil gelatinase associated lipocalin (NGAL) [167]. The 
antimicrobials within specific granules predominantly function to inhibit microbial survival and 
growth through sequestration of metals [167]. However, there are some that are also capable of 
interacting with microbial components to impact membrane integrity [167]. 
Tertiary (Gelatinase) granules. 
As with specific granules, gelatinase granules also have cargo to assist in movement of 
neutrophils across vasculature and through tissues [167]. One of the proteins contained within 
gelatinase granules is matrix metalloprotease-9 (MMP-9), referred to as gelatinase, from which the 
granule name was derived [167]. The activity of MMPs is inhibited within granules, as it is stored 
as a pro-form which undergoes cleavage upon granule release to activate the enzyme [167]. In 
comparison to azurophilic and specific granules, gelatinase granules are released earlier and with 
milder stimulus, such as the bacterial peptide mimetic, N-formylmethionyl-leucyl-phenylalanine 
(fMLF) [167].  
Secretory vesicles. 
Although secretory vesicles are not strictly granules, but more so plasma membrane 
derived vesicles, they are still classified as one of the four granule subtypes neutrophils possess 
[167]. Secretory vesicles are the last of the four granules to be formed and require the least stimulus 
to trigger release with fMLF sufficient to cause substantial release [153]. The function of secretory 
vesicle release is to prime neutrophils to respond to additional signals that an infection is occurring, 
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and begin moving toward the site of infection [167]. Through release of secretory vesicles, 
membrane receptors are displayed, such as formyl peptide receptors, the β2 integrin, complement 
receptor 3 [CR3], in addition to others [167]. The main cytoplasmic component of secretory vesicles 
is albumin, due to the endocytic nature of formation [167]. Surface expression of secretory vesicle 
receptors decreases over time without further stimulus, as receptors are removed through 
endocytosis of the plasma membrane [167].  
As mentioned previously, neutrophil granules are released with specific order mediated 
through tightly regulated pathways. For degranulation to occur, Ca2+ must be mobilized from 
intracellular stores, along with rearrangement of the actin cytoskeleton [155, 161, 170]. A barrier of 
cortical actin exists below the plasma membrane of neutrophils, impeding the release of granules 
[169, 171]. For granules to be released, this actin barrier must be broken down to provide access 
to the plasma membrane for fusion [148, 171]. Secretory vesicles, gelatinase and specific granules 
are distal to the plasma membrane, residing closer to the nucleus and require a cytoskeleton 
dependent shuttling to reach the plasma membrane [167]. Conversely, a subset of azurophilic 
granules are located just below the plasma membrane and do not require shuttling via the 
cytoskeleton from further cytoplasmic recesses [171]. Exocytosis is coordinated through a complex 
network of regulatory proteins consisting of Rac2, RhoA, Rab27a, Gem-interacting protein (GMIP), 
and other cytoskeletal interacting proteins [154, 155, 167, 171, 172]. Through fine-tuned regulation 
of the degranulation process, neutrophils rapidly respond to signals of invasion and coordinate 
movement to the site of infection, judiciously releasing the possessed weaponry either into the 
phagosomal compartment for minimal collateral damage, or into the extracellular space when 
phagocytosis fails to contain the infection [155, 158, 173]. 
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Figure 1-2: Neutrophil Granules. 
Neutrophils have four types of granules that each contain different cargo. Granules are released 
in response to stimuli in a graded manner. The first granule to be released are specific vesicles 
that function to increase the number of receptors on the plasma membrane. The second granule 
released are gelatinase granules that release proteases to increase the ability of neutrophils to 
move out of the vasculature and into the target tissue. Second to last to be released are specific 
granules which contain antimicrobials that function to target bacteria or sequester metals known 
as nutritional immunity. While azurophilic granules are the last to be released, they contain the 
most potent antimicrobials.  
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Neutrophil extracellular traps (NETs). 
Failure of phagocytosis, ROS, and degranulation to contain the infection cause neutrophils 
to rely on decondensing and release of DNA to entrap microorganisms [149, 156, 165, 174, 175]. 
Historically release of neutrophil extracellular traps (NETs) has been viewed as a last ditch defense 
mechanism for protecting the host as release of NETs was thought to kill neutrophils. Classical 
NETosis, in which the neutrophil granule and nuclear membranes are compromised, renders 
neutrophils no longer viable and is a death pathway independent of apoptosis [175, 176]. However, 
recent studies now suggest that neutrophils have a second mechanism which differs from suicidal 
NETosis, where the nucleic material is released in a membrane enclosed vacuole that allows the 
neutrophil to continue to fight against the infection, referred to as vital NETosis [177].  
Nuclear decondensation and membrane perforation requires participation from several 
neutrophil pathways. In order for NETosis to occur, granule membranes must be perforated, along 
with the nuclear and plasma membranes [175, 176]. Membrane rupture must occur in order for 
neutrophil elastase (NE), myeloperoxidase (MPO), and peptidylarginine deiminase 4 (PAD4) to 
enter into the nucleus, where each functions to modify DNA packaging through histone 
modifications [174-176]. In addition to the requirement of NE, MPO, and PAD-4, neutrophils also 
require activation of protein kinase C (PKC), NADPH oxidase, and the lipoxygenase pathway in 
order to rupture the cellular membranes and release nucleic material [178, 179]. As a result of 
granule and plasma membrane rupture, DNA from the neutrophil is adorned with granule 
components, such as NE, MPO, and others, in addition to cytosolic proteins such as the metal 
sequestration protein, calprotectin (SA100A8/9) [157]. Together, nucleic acid entraps the invading 
organism, while granule contents continue a defensive program in an attempt to starve and kill the 
invader. After expulsion of genomic material, granules contents, and formation of ROS, with nothing 
left to defend the host, depleted neutrophils must rely upon incoming neutrophils and other 
phagocytic cells to carry forth the tide of defense.  
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Neutrophils modulate the immune response through release of Leukotriene B4. 
Neutrophils produce an assortment of cytokines and chemokines as signals to other cells 
to relay the urgency and severity of response required. Of the inflammatory mediators possessed 
by neutrophils, leukotriene B4 (LTB4) is the first to be released, and one of the most potent 
chemoattractants [180, 181]. LTB4 is a lipid derived from membrane arachidonic acid (AA) through 
a series of enzymatic processes. To produce LTB4, AA is cleave from membranes, such as the 
nuclear envelope, plasma membrane, or membrane bound vesicles in the cytoplasm [182, 183]. 
Cleavage of AA from membranes occurs via activation of phospholipase A2 (PLA2), thereby 
increasing the free AA concentration within the cell [184]. In order to convert AA into other products, 
5 lipoxygenase (5-LO) must be activated and translocated to a membrane enriched in 5 
lipoxygenase activating protein (FLAP) [185, 186]. 
Regulation of 5-LO activity is multi-faceted (Figure 1-3). Phosphoylation by ERK1/2 and p-
38 have been indicated to increase 5-LO activity, while phosphorylation through PKA acts in an 
opposing manner to decrease 5-LO activity [187-191]. Binding of AA to 5-LO blocks interaction with 
PKA and limits the ability of PKA to phosphorylate 5-LO and thereby decrease 5-LO activity [190]. 
In addition to modification through phosphorylation, 5-LO also binds to Ca2+ and increases the 
affinity of 5-LO for phosphytidyl choline (PC), driving 5-LO toward association with PC enriched 
membranes where FLAP also resides [190, 192]. While coactisin like protein (CLP), a cytoskeleton 
interacting protein, is also an interacting partner with 5-LO, the exact role CLP plays in the activity 
of 5-LO is not fully apparent [186]. Upon activation and translocation of 5-LO, a secondary cascade 
of enzymatic reactions occur. The 5-LO product 5-HpETE is converted to LTA4 and subsequently 
converted to LTB4 through the action of LTA4 hydrolase (LTA4H) [190]. Once LTB4 has been 
produced, release into the extracellular space is currently proposed to be mediated by exosomes 
[193, 194]. This hypothesis is supported by data showing LTB4 does not freely diffuse out of cells, 
and that there is a rate limiting step to release [195]. Additionally, free LTB4 has a shorter half-life 
in comparison to exosome encased LTB4, which ties into the chemoattractant nature of LTB4 to 
signal over long distances [194].  
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Figure 1-3: Synthesis pathway for LTB4. 
Human neutrophils produce LTB4 to a greater extent than most other innate immune cells. LTB4 is 
a potent inducer of chemotaxis, but is also able to modulate immune cell antimicrobial activities. 
Production of LTB4 is a multistep process that can involve integration of multiple signaling 
pathways. Receptor sensing of PAMPs triggers activation of the MAPK pathway in addition to 
release of Ca2+ from intracellular stores. Phosphorylation of 5-LO and/or association with Ca2+ 
triggers translocation of 5-LO to a lipid membrane (i.e. nucleus or lipidosome) while also activating 
cPLA2 to liberate arachidonic acid (AA). Through the combined activity of 5-LO and 5-LO activating 
protein (FLAP), AA is modified to form 5(S)-HpETE and further processed by 5-LO to form LTA4. 
Ultimately, LTA4 is processed by LTA4 hydrolase to form LTB4.  
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While LTB4 is a potent chemoattractant, it is also capable of increasing the antimicrobial 
activity of multiple immune cells [196-199]. LTB4 has been shown to impact neutrophil ROS 
production, degranulation, NETosis, and increase the efficacy of phagosomal degradation [200-
202]. In addition to the impact of LTB4 on neutrophils, LTB4 also modulates cytokine production in 
macrophages, as well as impacts dendritic cell (DC) presentation to T cells and cytokine release 
[200, 203, 204]. The influence of LTB4 on DC presentation links the impact on innate immune cells 
to influencing of adaptive immune responses as well [196, 197, 204-206] [207]. Taken together, 
LTB4 plays a crucial role in successful clearance of microbial infections and has been demonstrated 
to be important for clearing infections by pathogens such as Klebsiella pneumonia, Borrelia 
burgdorferi, and also for fungal and parasitic infections [198, 201-203, 208-210].  
Caveats when working with neutrophils 
It is important to note that during in vitro assays, how neutrophils are handled can impact 
observed phenotypes more than other host cells. For example, the process of adhering neutrophils 
to substrates can modify the activation state and trigger release of granules that would not occur 
without additional stimulation when kept in suspension. Simple differences, such as using 
suspension versus adherent neutrophils, and the charge or composition of the surface adhered to, 
can modulate other responses such as ROS production and phagocytosis [211-214]. Interestingly, 
even signaling pathways can change pending the cues a neutrophil receives. In suspension, 
neutrophils signal through the MAPKs ERK and p38, yet upon adherence, JNK is then able to relay 
in the phosphorylation cascade [215-217]. The differential responses must be kept in mind when 
thinking about how neutrophils are signaling and responding to microbial infections. 
Considerations also need to be made when comparing responses between mice and 
humans. For example, human TLR4 is more sensitive to LPS than the mouse counterpart, resulting 
in a stronger inflammatory response in humans versus mice [218]. Not only is TLR4 different 
between mice and humans, mice also have additional TLRs not encoded by humans [218]. Other 
receptors also differ between mice and humans, such as the formyl peptide receptors (FPR) and 
complement receptors (CR) [218, 219]. In a very generalized summary, mouse receptors have less 
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affinity/activity than human receptor counterparts [218]. Furthermore, inducible nitric oxide 
synthase activation requires different cytokine signals in mouse cells versus human [220]. Not only 
are there differences in receptor sensitivity and activation, there are also differences in cellular 
content. Human azurophilic granules have bacterial permeability inducing protein and defensins 
that are not part of the cargo in mouse azurophilic granules [218]. Moreover, although mouse 
azurophilic granules have been shown to contain myeloperoxidase (MPO), human azurophilic 
granules have up to 10x more MPO than murine azurophilic granules [218]. Therefore, what is 
observed during in vitro studies using mouse neutrophils may not always translate to human 
neutrophils and vice versa, highlight the need to verify results with mouse cells in primary human 
cells. 
Inhibition of neutrophil antimicrobial responses by Y. pestis. 
With the array of antimicrobial mechanisms neutrophils can deploy to defend against 
infection by microorganisms, they are one of the most vital innate immune cells for controlling 
infection. During Y. pestis pneumonic infection, there is an early non-inflammatory phase, where 
neutrophils are not recruited into the lungs until 36-48h post infection [221]. Similarly, the 
inflammatory cytokines (KC and MIP-2) also do not increase until the same time frame [146, 222]. 
Concomitant with the arrival of neutrophils to the site of infection, the non-inflammatory phase ends 
and an inflammatory response is mounted, resulting in necrosis and ultimately death of the host 
[36, 223]. If neutrophils are artificially recruited to the site of infection earlier than normal, a decrease 
in bacterial burden and an increase in overall host survival are observed in a mouse model of 
infection [146], indicating that maintenance of this early non-inflammatory environment is important 
to establish infection.  
During colonization by Y. pestis, resident neutrophils have been shown to be a primary 
target for T3SS effector translocation [42, 43]. These interactions allow Y. pestis to inhibit several 
neutrophil antimicrobial responses (Figure 1-4) [166, 224]. YpkA, YopE, YopH, and YopT inhibit 
cytoskeleton rearrangements via interactions with Rac2 and RhoA to suppress phagocytic uptake 
of Y. pestis [72-74, 76-82, 166, 225]. Targeting of Rac2, a component required for activation of the 
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NADPH oxidase, by YopE also contributes to inhibiting ROS, but requires complementary actions 
by YopJ inhibition of MAPK signaling and YopH targeting of the focal adhesion complex to fully 
inhibit ROS by neutrophils [226, 227]. Finally, YopJ inhibition of MAPK signaling also inhibits 
release of IL-8 by neutrophils, though additional, yet to be identified, Yops are also required for full 
inhibition of release [224]. However, the pathways regulating granule release and LTB4 production 
in neutrophils have not been previously examined in the context of Y. pestis infection. The pathways 
regulating granule release and LTB4 production are also regulated by the same host factors known 
to be targeted by the Yops (e.g. MAPK pathway, Ca2+ flux, and Rac/Rho signaling) [154, 155, 162, 
188, 190, 192, 228]. Because the pathways are common between these neutrophil antimicrobial 
responses, the likelihood that these processes are also inhibited by Y. pestis during infection, and 
contribute to the ability of the bacterium to subvert killing by neutrophils, is increased. Moreover, 
while much of our understanding of the host targets for individual Yops has come from studies in 
macrophages, data showing direct interaction between specific Yops and their predicted host 
targets in neutrophils lags behind. Understanding the mechanisms of how Y. pestis inhibits 
neutrophil responses early during infection will shed light on how Y. pestis maintains an early non-
inflammatory environment beneficial to Y. pestis survival.  
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Figure-1-4: Y. pestis Yop Effector Protein Impact on Neutrophil Antimicrobial Responses. 
Injection of bacterial effector proteins into the cytosol of neutrophils allows for interaction with host 
cell signaling pathways. YopJ is known to inhibit release of IL-8 from neutrophils, but interaction 
with MAPKs in neutrophils has not been demonstrated. YopH acts through interaction/inhibition of 
FAC proteins to inhibit intracellular Ca2+ flux that is required for multiple downstream effects in 
neutrophils, such as degranulation, ROS production, and release of LTB4 and. YpkA, YopE, and 
YopT modulate actin cytoskeletal rearrangement pathways through targeting of Rac and RhoA, 
inhibiting phagocytosis and the ability of neutrophils to move. While the role of Yop effector proteins 
have been assessed (red) for inhibition of phagocytosis, the respiratory burst, and IL-8 release, the 
impact on granule exocytosis and LTB4 production has not been determined (purple).  
30 
 
RESEARCH OBJECTIVES 
Interactions with host innate immune cells dictate whether Y. pestis is successfully cleared 
by the infected host. Two of the most essential host phagocytic cells responsible for clearing 
infections are macrophages and neutrophils. An inherent interplay exists between these cells, as 
signaling from one cell type influences the antimicrobial properties of the other through release of 
cytokines and chemokines. The goal of this work is to better understand how Y. pestis survives the 
initial onslaught of phagocytic cells both intra- and extracellularly, while maintaining an environment 
that does not incite inflammation until late in the infection process. Y. pestis is able to survive and 
replicate within macrophages, yet known virulence factors, such as the T3SS are not required. 
Many pathogens manipulate Rab trafficking to establish a replicative niche within macrophages. 
Therefore, I hypothesize that Y. pestis modulates host Rab GTPases to avoid lysosomal 
degradation, establish the YCV, and buy time to increase expression of the T3SS to subsequently 
target neutrophils. Furthermore, whether Y. pestis inhibits release of granules and LTB4 has never 
been evaluated, but I hypothesize that Y. pestis actively inhibits neutrophil granule and LTB4 
release using the T3SS effector proteins. Together, my overarching hypothesis is that Y. pestis 
manipulates Rab GTPases to survive within macrophages, buying time to express the T3SS, which 
is then used to inhibit neutrophil antimicrobial capabilities including granule and LTB4 release, 
ultimately maintaining the early non-inflammatory environment observed during Y. pestis infection.  
To test this hypothesis, I have formulated specific questions with briefly described research 
objectives to answer those questions outlined here:  
1. How does Y. pestis avoid phagolysosomal mediated killing within macrophages?  
To address this question, I: 
a. Completed an RNAi screen to survey Rab GTPases required for intracellular 
macrophage survival. 
i. Identified Rab GTPases important for Y. pestis intracellular survival which 
are recruited or excluded from the YCV in order to modulate vesicular 
trafficking. 
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2. Does Y. pestis modulate the neutrophil antimicrobial response in order to maintain an early 
non-inflammatory host environment?  
In an attempt to answer this question, I: 
a. Measured whether the four neutrophil granules are released in response to Y. 
pestis. 
i. Evaluated whether granule release is inhibited by the Ysc T3SS. 
ii. Determined which Yop effector protein(s) mediate inhibition of granule 
release. 
b. Measured LTB4 production and release in response to Y. pestis infection of 
neutrophils 
i. Determined if the T3SS inhibits release of LTB4 from human neutrophils.  
ii. Determined which Yop effector protein(s) are mediating inhibition of LTB4 
release and the host pathways which are targeted. 
The subsequent chapters present data to improve our understanding of how Y. pestis evades 
degradation by macrophages and neutrophils to survive, establish a replicative niche, and avoid 
an early inflammatory response. 
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                                     MATERIALS AND METHODS
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Cell Culture, Bacterial Strains, and Plasmids 
RAW264.7 macrophages were obtained from ATCC and cultured in Dulbecco modified Eagle 
medium (DMEM) containing 100 mM glucose plus 10% fetal bovine serum (FBS) (Biowest) at 37°C 
and 5% CO2. For plasmid transfection of RAW264.7 macrophages, 0.5 μg of plasmid (EGFP-Rab) 
was transfected using JetPrime (Polyplus) as described by the manufacturers.  
Y. pestis CO92 pCD1(-) [5] was cultivated at 26°C in Difco brain heart infusion broth (Becton, 
Dickinson, and Co.). E. coli K-12 DH5α (New England Biolabs) was cultivated at 37°C in Luria-
Bertani broth (Miller) (Becton, Dickinson, and Co.). Bioluminescent (CO92LuxPtolC) [5] or fluorescent 
(pGEN222::mCherry) [118] derivative strains were used as indicated for infections. Y. pestis was 
inactivated by incubating bacteria with 2.5% paraformaldehyde (PFA) for 30 min at room 
temperature as previously described [118] Extracellular Y. pestis and E. coli were killed with 16 
µg/ml gentamicin for 1 h, followed by maintenance in 2 µg/ml gentamicin. 
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Rab GTPase RNAi Screen 
The Rab GTPases RNAi screen was performed as previously published [119]. Small interfering 
RNAs (siRNAs) from the Silencer siRNA mouse genome library v3 (Ambion) were used to forward 
Table 2-1: Bacterial Strains 
Descriptive name  Genotype Strain 
Number 
Source 
CO92 T3+ CO92 pCD1(+), pgm(+), pMT(+), pst(+), 
LuxpcysZK 
MBLYP043 [5] 
CO92 T3-  CO92 pCD1(-), pgm(+), pMT(+), pst(+) YPA035 [5] 
CO92 T3+  MBLYP043 pgm(-) YPA143 This work 
CO92 T3-  CO92 pCD1(-), pgm(+), pMT(+), pst(+), 
LuxPtolC 
YPA050 [122] 
KIM T3+ KIM1001 pCD1(+), pgm(-), pMT(+), pst(+) JG150A [229] 
KIM T3-  KIM1001 pCD1(-), pgm(-) JG152B This work  
KIM T3E- KIM1001 pCD1(+) (yopHΔ3-467 yopEΔ40-
197 yopKΔ4-181 yopMΔ3-408 ypkAΔ3-731 
yopJΔ4-288 yopTΔ3-320)), pgm(-), pMT1(+), 
pPCP1(+) 
JG714 This work  
+A  JG917::+ypkA JG730 [229] 
+E JG917::+yopE JG733 [229] 
+H JG917::+yopH JG734 [229] 
+J JG917::+yopJ JG735 [229] 
+K JG917::+yopK JG736 [229] 
+M JG917::+yopM JG732 [229] 
+T JG917::+yopT JG708 [229] 
ΔA JG150A ΔypkA JG593 [229] 
ΔE JG150A ΔyopE JG517 [229] 
ΔH JG150A ΔyopH JG589 [229] 
ΔJ JG150A  ΔyopJ JG525 [229] 
ΔK JG150A ΔyopK JG523 [229] 
ΔM JG150A ΔyopM JG583 [229] 
ΔT JG150A ΔyopT JG713 [229] 
CO92 T3-::pGEN222-
mCherryK 
CO92 pCD1(-), pgm(+), pMT(+), pst(+), 
pGEN222::mCherry 
YPA127 [5, 119] 
E. coli::pGEN222-
mCherry  
DH5α- pGEN222::mCherry LOU123 [119] 
KIM D-19 KIM D-19 pCD1(+), pgm(-), pMT(+), 
pst(+), LuxPtolC 
YPA119 [119] 
Y. pseudotuberculosis  
T3+ 
IP32593 pYV(+) MBL256 [2] 
Y. pseudotuberculosis  
T3- 
IP32593 pYV(-) LOU016 [2] 
Y. enterocolitica  T3+ JB580 pYV(+) MBL016 [230] 
Y. enterocolitica  T3- JB580 pYV(-) MBL077 [230] 
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transfect RAW264.7 macrophages. Three siRNAs targeting each gene were pooled together for 
the screen. siRNAs were suspended in 20 µl Opti-MEM (final concentration of 1 µM) and mixed 
with 10 µl of 0.03% (vol/vol) Lipofectamine RNAiMax/Opti-MEM. The mixture was added to each 
well of a 96-well, white, flat bottom, plate (Greiner Bio One). Scrambled siRNA (negative control; n 
= 3) and Copβ1 siRNA (positive control; n = 3) were used as negative and positive controls, 
respectively for transfection efficiency and plate-to-plate variation. The plates were incubated at 
room temperature for 10 min, before adding 80 µl of DMEM plus 10% FBS (HyClone) at 1 x 104 
RAW264.7 macrophages. The cells were incubated for 48 h prior to infection with Y. pestis 
CO92LuxPtolC pCD1(-) (multiplicity of infection [MOI] of 10). The infection was synchronized using 
centrifugation (200 x g) for 5 min. Extracellular bacteria were killed with gentamicin as described 
above after incubation for 20 min. Bioluminescence at 20 min and 2 h and 10 h was used to quantify 
intracellular bacteria post-infection using a Synergy 4 plate reader (BioTek; 1-s read with sensitivity 
set at 150). Cell viability was determined using Alamar Blue (Life Technologies) after the 10 h read 
by adding 10 µl of Alamar Blue to each well and incubating for 2 h at 37°C and 5% CO2. 
Fluorescence (excitation wavelength, 560 nm; emission wavelength, 600 nm) was determined 
using a Synergy 4 plate reader. The average of the scrambled-siRNA control wells were used as 
controls for comparing to. Using the formula: 1 - (3 X (SD Copβ1 RLU – SD scrambled RLU)/(AVG 
scrambled RLU – AVG Copβ1 RLU)) where SD is the standard deviation and AVG is the average, 
a Z factor (Z’) was calculated from each plate. Plates with Z’= of <0.3 were repeated. The following 
formula: (siRNA RLU/AVG Copβ1 RLU)/(AVG scrambled RLU/AVG Copβ1 RLU) was used to 
normalize intracellular survival for each plate. Screen selection criteria was set at ≥50% inhibition 
of Y. pestis survival with ≤50% cytotoxicity as measured by alamar blue. Selection criteria was set 
to ≥50% inhibition of Y. pestis survival and ≤50% cytotoxicity base on three independent siRNA 
tests for a validation screen. 
Fluorescence Confocal Microscopy 
For confocal microscopy, cells were fixed to coverslips with 2.5% paraformaldehyde for 30 min. All 
coverslips were mounted with Prolong Gold with DAPI (Life Technologies) and imaged on a Zeiss 
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LSM 710 laser confocal microscope. Co-localization was determined using the COLOC module in 
IMARIS 8.0 (Bitplane). 
Neutrophil Studies: Bacterial Growth Conditions 
Bacterial strains used in these studies are listed in Table 2-1. Prior to infection, Y. pestis was 
cultured for 15 to 18 h at 26°C in Difco brain heart infusion (BHI) broth (BD Biosciences) with 
aeration. Cultures were diluted 1:10 in fresh BHI broth containing 20 mM MgCl2 and 20 mM Na-
oxalate and cultured at 37°C for 2 h with aeration to induce expression of the T3SS. Bacteria were 
centrifuged and re-suspended in LPS-free Krebs-Ringer phosphate buffer (pH 7.2) containing 0.2% 
dextrose (Krebs) buffer for infection. Y. pestis was killed using either 1% PFA for 30 min, or heat 
killed by incubating Y. pestis at 60°C for 30 min. The killed bacteria were pelleted and re-suspended 
in Krebs buffer prior to infection. 
Human Neutrophil Isolation 
Use of human neutrophils was approved by the University of Louisville’s Institutional Review Board 
(IRB) guidelines (approval no. 96.0191). Neutrophils were isolated from peripheral blood of healthy, 
medication-free donors as described previously [231]. Neutrophil isolations yielded >95% purity 
with >97% viability by Trypan blue exclusion staining and were used within 1 h of isolation. For 
RNAseq analysis, negative selection using EasySep™ antibody mediated magnetic separation 
was used to remove cells other than neutrophils, yielding highly pure (> 99%) neutrophils as 
previously described [232]  
Human Neutrophil Infection 
Throughout these studies, all infections were performed in suspension as opposed to using 
adherent neutrophils. Cells in suspension were used primarily for two reasons: 1) The activation 
state of cells in suspension is closer to patrolling blood neutrophils, and. 2) All four granules can 
be assayed for release, unlike adherent neutrophils where the adherence process stimulates 
release of secretory vesicles. An important consideration for studies performed with cells in 
suspension is that the infections cannot be synchronized by centrifugation, and thus require higher 
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MOIs to ensure bacterial interactions with host cells, compared with assays using adherent cells 
that can be synchronized by centrifugation. 
Neutrophils (4x106 cells; for Western blotting, 8x106 cells were used) were re-suspended in Krebs 
buffer or RPMI + 5% BSA and, where indicated, incubated at room temperature (RT) for 30 min 
with 1 µM latrunculin A (catalog [cat.] no. 428021; Sigma), 20 µM U0126 (cat. no. 70970; Cayman), 
50 nM LY293111 (cat. no. 10009768; Cayman), or 3 µM (5Z)-7-oxozeaenol (cat. no. 17459; 
Cayman). Neutrophils were infected at a multiplicity of infection (MOI) of 10 or 100 and incubated 
for 30 min, 1h or 3 h in a 37°C water bath with gentle agitation. Coinfections were performed at a 
final MOI of 100 (50 for each strain), and bacteria were mixed together prior to adding to the cells. 
For secretory vesicles, specific and azurophilic granule exocytosis, the increases in plasma 
membrane expression of CD35, CD66b and CD63, respectively, were measured by flow cytometry 
as previously described [153]. To measure release of calprotectin, or LTB4, separate samples were 
centrifuged, and cell-free supernatants were transferred to new tubes containing Halt phosphatase 
and protease inhibitor cocktail (cat. no. 78442; Thermo Fisher Scientific), except for calprotectin 
samples and stored at -80°C. Calprotectin samples where neutrophils were treated for 3 h with 
PMA were unfrozen and mixed with a quantity of Y. pestis or E. coli equivalent to what would have 
been present during the neutrophil infection for the volume used, to assess degradation of 
calprotectin by proteolytic activity (e.g. 4x108 CFU were added to 4x106 neutrophils to achieve an 
MOI of 100 in 1mL. For 100uLs of the PMA stimulated supernatant, 4x107 CFU were used during 
the 3 h no cell incubation.) The samples were incubated at 37°C for 3 h. 
Measurment of Exocytosis by Flow Cytometry and ELISA  
Neutrophils were stained with fluorescein isothiocyanate (FITC)-labeled anti-CD63 (cat. no. 215-
040; Ancell), FITC-labeled anti-CD66b (cat. no. 305104; BioLegend), or PE labeled CD35 as 
markers for azurophilic, specific granules, or secretory vesicles, respectively. As antibody isotype 
controls, neutrophils were separately labeled with FITC-labeled anti-IgM (cat. no. 401108; 
BioLegend) or FITC-labeled anti-IgG1 (cat. no. 400108; BioLegend) on ice for 45 min before 
washing with FTA buffer (BD Biosciences) plus 0.05% sodium azide and fixing with 1% 
paraformaldehyde (PFA). Mean cellular fluorescence intensity (MCF) was measured using a 
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fluorescence-activated cell sorting (FACS) Aria flow cytometer (BD Biosciences) with isotype 
control values subtracted as previously described [233]. Human Calprotectin (cat. No 439707; 
BioLegend), mouse calprotectin (cat. no ab263885; Abcam) and LTB4 (cat. no. 520111; Cayman) 
levels were measured by enzyme-linked immunosorbent assay (ELISA) following the 
manufacturer’s protocols. 
Chemotaxis Assay 
Supernatants from infected neutrophils were filtered using a 0.2 µm syringe filter to generate 
conditioned supernatants. Naive neutrophils (1x106 cells/ml) were loaded into the upper chamber 
of a 24-well Transwell plate (Corning). The lower chambers were filled with Krebs buffer, 100 nM 
fMLF (Sigma), or the conditioned supernatants. After incubation for 30 min at 37°C, neutrophils that 
migrated from the upper chamber to the lower side of the Transwell membranes were fixed and 
stained with Hema 3 (ThermoFisher) and counted by microscopy as described previously [234]. 
Western Blotting 
After 30 min of infection, cell pellets were obtained by centrifugation (6,000 x gfor 30 s). Pellets 
were lysed using ice-cold lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% [vol/vol] Triton 
X-100, 0.5% [vol/vol] Nonidet P-40, 20 mM NaF, 20 mM NaVO3, 1 mM EDTA, 1mM EGTA, 5mM 
phenylmethylsulfonyl fluoride [PMSF], 2mM diisopropylfluorophosphate [DFP], 21 µg/ml aprotinin, 
and 5 µg/ml leupeptin). Lysates were mixed with Laemmli loading buffer and boiled for 10 min prior 
to snap cooling. Lysates were run on a 10% SDS-PAGE gel and immunoblotted with antibodies to 
phospho-ERK1/2, total ERK1/2, phospho-p38 MAPK, or total p38 MAPK (Cell Signaling) diluted 
1:2,000 in 10 ml of Tris-buffered saline plus 0.1% Tween 20 (TBST) plus 5% bovine serum albumin 
(BSA). The appropriate secondary antibodies were used at 1:50,000 (cat. no. A9169; Sigma-
Aldrich; cat. no. 31430; ThermoFisher Scientific). SuperSignal West Femto maximum-sensitivity 
substrate (cat. no. 34095; ThermoFisher Scientific) was used to detect antigen-antibody binding. 
Densitometry was performed using ImageJ software to quantify bands, normalized using the total 
protein form. 
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In vivo Infection 
C57BL6 wild type mice aged 6-12 weeks were infected intranasally with either WT Y. pestis 
LuxcysZK  or Y. pestis pCD1(-)LuxcysZK at 1x104 CFU. Bacterial growth was monitored via CFU 
enumeration and BALF from the lungs was harvested at 12, 24, 48 h PI, or at the time of 
euthanasia.  
Statistics 
Degranulation and LTB4 data are the mean of five biological independent experiments. 
Phosphorylation data are the mean of three biological independent experiments. For all, neutrophils 
were harvested from both male and female donors and infections were performed on different days. 
Where appropriate, one-way analysis of variance (ANOVA) with Dunnett’s or Sidak’s post-test, as 
indicated in individual figure legends, was used for statistical analysis and performed using Prism 
8 (GraphPad). Unless noted, data are shown as the means ± standard error of the mean (SEM). 
For microscopy, each experiment analyzed at least 100 YCVs, and power analyses were performed 
post-hoc to ensure that appropriate sample sizes were analyzed. P values were calculated using 
one-way analysis of variance (ANOVA) using GraphPad Prism software.
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IDENTIFICATION OF RAB GTPASES CONTRIBUTING TO Y. PESTIS 
INTRACELLULAR SURVIVAL 
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INTRODUCTION 
Rab GTPases are proteins that shepherd intracellular vesicles to and from various 
locations within the cell. Over 70 Rab proteins are encoded within human cells and have specific 
subcellular localization [114, 235]. Activity of Rab GTPases requires several accessory proteins to 
assist Rab proteins in cycling between a membrane-GTP bound active state, to a cytosolic GDP-
bound inactive state [236]. GAP disassociation inhibitors (GDI) bind to inactive GDP-bound Rab 
GTPases and remove them from membranes [236]. GDIs bind the lipid anchoring prenyl group to 
protect the hydrophobic tail, removing the Rab from the membrane, and returns the Rab to the 
membrane of origin [236, 237]. Switching between an inactive GDP bound state and active GTP 
bound state is carried out through the action of GDP/GTP exchange factor (GEF) and the reversal 
from GTP to GDP is enhanced by GTP activation proteins (GAP) [236]. With the assistance of 
GAPs, GEFs, and GDIs, Rabs carry out membrane trafficking duties in association with other 
interacting proteins to systematically direct vesicle activities. Rabs associate with vesicles in all 
stages of vesicle life, from forming vesicles through membrane budding, to coating, transporting, 
uncoating/tethering, and fusing to the target membrane [238]. 
During phagosome maturation, a sequence of Rab proteins associate and disassociate 
from the vacuole. The early endosome ( which early phagsomes can be classified as) associate 
with Rab5 [113]. As the vacuole matures and progresses to fusion with lysosomes, Rab5 
dissociates from the vacuole membrane. Following the loss of Rab5, Rab7 is recruited and is 
required for fusion to lysosomes [113]. The elegant sequence of Rab recruitment and removal is 
essential to vacuole maturation. If disrupted, the endosome fails to mature, and the endosomal 
cargo is not exposed to enzymes like Cathepsin D or the phagosome may not undergo acidification 
through action of vATPases, ultimately resulting in endosomal cargo not being degraded [113]. 
Direct recruitment or exclusion of Rab proteins to or from the pathogen containing vacuole 
is a common way in which pathogens modulate phagosome maturation and remodel the vacuole 
into a niche for replication [239-245]. Hijacking host vesicular trafficking is a mechanism commonly 
exploited by intracellular pathogens and is an area of interest for better understanding the ways in 
which pathogens manipulate host cells to establish intracellular replicative niches. The exact 
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mechanisms pathogens use to target host factors are multitudinous and often carried out through 
the action of bacterial effector proteins. Some pathogens encode relatively few effector proteins, 
while others such as Legionella pneumophila encode more than 300 [246]. The effector proteins 
are delivered into the host cell through bacterially encoded secretion systems that act as molecular 
delivery systems from the cytosol of the bacteria, through the membrane, and deposit the substrate 
either outside of the bacterial cell, or within the host cell [67, 247]. Several different types of 
secretion systems exist, and many of them are able to deliver products to promote bacterial 
virulence. The T3SS, T4SS, and T6SS are capable of bridging both bacterial membranes and the 
host cell plasma/phagosomal membrane to directly deliver effector proteins into target cells [67].  
Understanding the mechanisms Y. pestis uses to survive and replicate within macrophages 
is important for developing potential therapeutic strategies to prevent bacterial survival and 
replication. Previous studies have established that Y. pestis resides within a membrane bound 
compartment for the duration of the time Y. pestis is within macrophages [108, 117, 248]. Within 
this membranous compartment, Y. pestis is not exposed to acidic and degradative factors as would 
be expected for a non-pathogenic bacterium [117]. Instead, Y. pestis avoids fusion with the 
lysosome and the pH within the YCV remains between pH 6.5 and 7.5 for the duration of the time 
within macrophages [109, 117-119]. 
We have shown that avoidance of acidification is dependent on the host factors Rab1b and 
Rab4a [118, 119]. Inhibition of fusion with the lysosome is an active process, as paraformaldehyde-
fixed Y. pestis traffics to the lysosome and is degraded within an acidic vacuole [118]. Intriguingly, 
neither Rab5 or EEA1, nor Rab7 or Cathepsin D, markers for early endosomes and mature 
phagolysosomes, respectively, have been found in association with the YCV [117]. Whether the 
lack of Rab5 indicates an alternative mechanism of entry into the cell, or if Rab5 association and 
disassociation from the YCV is too rapid to detect, has not been determined. More recently, we 
have shown that Rab1b, 4a, and 11b are recruited to the YCV [118, 119], and 60-80% of YCVs 
eventually develop into autophagosomes, highlighted by association with LC3-II and acquisition of 
a second membrane [117]. 
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Autophagy is a cellular recycling process that breaks down vacuolar contents to reuse the 
nutrients liberated [128]. Furthermore, autophagy is a mechanism to inhibit the growth of pathogens 
residing within the cytosol [249]. However there is evidence that autophagy can be beneficial to 
intracellular pathogens [250]. Specifically evidence from Salmonella suggests that autophagy may 
present a way for pathogens which reside in vacuoles to acquire nutrients [244, 251]. Rab11b, 
which interacts with the autophagy pathway, also appears to be recruited to the YCV, and there is 
evidence that it is the bacteria within autophagosomes which are able to replicate within 
macrophages [117, 130]  
Because Rab GTPases are commonly targeted by bacterial pathogens to subvert 
lysosomal degradation by macrophages, and three Rab GTPases have already been shown to be 
essential for Y. pestis survival within macrophages, I was interested to know whether additional 
host Rab GTPases were essential for intracellular survival and biogenesis of the YCV. Using an 
RNAi approach, I was able to show that six Rab GTPases in addition to Rab1b, 4a, and 11b are 
required for Y. pestis to survive in macrophages. Moreover, I defined the relationship between the 
YCV and three of the new Rab targets during Y. pestis infection of mouse macrophages.  
RESULTS  
RNAi screen identifies Rab GTPases required for Y. pestis survival within macrophages. 
Rab GTPases are a common target for bacterial pathogens to subvert host cell vesicular 
trafficking that would otherwise be detrimental to the survival and/or replication of the pathogen 
[252]. To identify additional Rab proteins required by Y. pestis for macrophage intracellular survival, 
a Rab GTPase specific RNAi screen was performed in a mouse macrophage cell line. A pooled 
siRNA approach was used, similar to that reported by Connor et al. [119]. Briefly, three siRNA 
targeting a single Rab protein were pooled and transfected into RAW264.7 macrophages. The 
macrophages were then infected with a bioluminescent Y. pestis (Y. pestis CO92 pCD1(-) LuxPtolC) 
and intracellular survival was monitored as a function of bioluminescence, and host cell survival 
was monitored by Alamar blue staining. For this primary screen, positive cutoff criteria was set as 
50% reduction in intracellular Y. pestis survival compared to scrambled siRNA, and less than 50% 
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decrease in cell viability. Of the 39 Rab GTPases screened, RNAi of 13 Rabs met this criteria 
(Figure 3-1). Importantly, the three Rab GTPases previously shown as required for Y. pestis 
intracellular survival, Rab1b, 4a, and 11b, were among these hits [119].  
While siRNA technology has come a long way, one potential problem is false positive 
results from off target inhibition of unattended targets, which can be exacerbated in pooled siRNA 
screens. A common technique to increase confidence in RNAi screens, and to reduce the likelihood 
of false positives, is to validate primary hits from a pooled siRNA screen with a secondary screen 
in which the pooled siRNAs are deconvoluted (i.e. each siRNA from the pool is individually 
screened for phenotypes). In this scenario, if a phenotype is due to an off target artifact, it should 
only occur with one of the three siRNAs. If the phenotype is validated with two or more of the 
siRNAs, it is then significantly more likely to be a true positive hit and is less likely to be an off target 
artifact. Using this approach, RAW264.7 cells were transfected with individual siRNAs (three 
siRNAs for each gene) for the 13 Rab GTPases identified in the primary pooled siRNA screen cells 
were then infected with Y. pestis CO92 pCD1(-) LuxPtolC or Y. pestis KIMD19 pCD1(+) LuxPtolC., Genes 
in which at least three of the six individual infections resulted in ≥50% reduction of intracellular 
survival were considered validated hits.  
From the 13 primary hits, eight Rab GTPases were validated as required for Y. pestis 
intracellular survival within macrophages (Figure 3-2). Moreover, as I expected, there were not 
significant differences in intracellular survival between a strain caring the pCD1 plasmid (encoding 
the T3SS) and one lacking pCD1, supporting previous data that the T3SS is not required for YCV 
biogenesis [117].  
Rab GTPases are differentially localized to the YCV. 
To influence vesicular trafficking of the phagosome, many intracellular pathogens recruit 
specific Rab proteins to the vacuole membrane [252]. Each Rab GTPase has a unique role in 
maintaining membrane traffic and must directly insert into the target membrane to function [114]. 
The coordinated interactions between the membrane, Rab GTPase, Rab interacting partners, and 
other host structures, such as the cytoskeleton, cause membrane shuttle flow from one cellular 
location to another via vesicle transport [115]. Disruption of Rab membrane association/localization 
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alters membrane trafficking, and can lead to errant trafficking events. For example, if membrane 
targeted to the golgi errantly localizes with Rab11b, instead of Rab1b, the vesicle would traffic as 
a part of the recycling pathway, not to the golgi apparatus. Therefore, I sought to determine if Y. 
pestis recruited the validated Rab GTPases to the YCV during infection as a way to alter 
phagosome maturation. We previously characterized localization of Rab4a and Rab11b [119], 
which left localization of six Rab GTPase hits as unknowns. I prioritized four of the six remaining 
Rab proteins by degree of change in intracellular survival observed in the validation screen, giving 
higher priority to those whose RNAi resulted in greatest inhibition of Y. pestis intracellular survival 
(2b>23>13>22a>40b>20). I then also considered the functional categories of the individual Rab 
proteins. The Rab proteins identified from the screen generally fall into one of four functional 
categories: recycling (Rab23, 13, and 22a), sorting endosome (Rab20), secretory (Rab40b), or 
retrograde (Rab2b) trafficking. Three of the top four hits fall in the recycling pathway, which we 
have already established as being important for YCV biogenesis [119]. Therefore, to expand our 
analysis to include additional pathways, I chose to examine Rab20 over Rab23 because 
interactions with the sorting endosome is likely the earliest step in the YCV biogenesis process, 
and the role of the sorting complex in the context of Y. pestis infection is not as well understood. 
Therefore, Rab2b, 13, 22a, and 20 were chosen for further characterization.   
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Figure-3-1: Rab proteins identified as essential for Y. pestis intracellular survival. 
RAW 264.7 macrophages were transfected with three siRNAs targeting 39 different Rab genes. 
Forty-eight hours after transfection, cells were infected with Y. pestis CO92 pCD1(-) LuxPtolC (MOI 
of 10), and intracellular bacterial numbers were determined by bioluminescence (RLU) at 2 h or 10 
h post-infection. Scrambled (Scr) siRNA was used as a negative control. Data is shown as the 
mean percent of intracellular bioluminescence at 10 h post-infection compared to 2 h post-infection 
for two independent replicates. Values for which Y. pestis intracellular growth was inhibited ≥50% 
compared to scramble are highlighted in the gray shaded area. Predicted trafficking pathways each 
identified Rab belongs to is indicated by color: red = recycling; blue = retrograde trafficking; purple 
=sorting; green = the secretory pathway; white = did not meet cutoff criteria.  
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To test whether Y. pestis recruits these Rab proteins to the YCV, RAW264.7 macrophages 
overexpressing GFP-tagged Rab proteins were infected with Y. pestis CO92 pGEN222::mCherry 
(Yp) or E. coli K-12 pGEN::mCherry (Ec), the latter bacterium is non-pathogenic and readily 
degraded by macrophages. At 20 min, 80 min, or 10 h post infection, infected cells were fixed and 
imaged using confocal microscopy. Imaris (Bitplane) was used to identify co-localization of Rab-
GFP proteins with the bacteria containing vacuoles (Figure 3-3). By 10 h post infection, no E. coli 
could be identified, which is evidence of bacterial degradation. At early time points when E. coli 
was visible, less than 10% of E. coli vacuoles co-localized with Rab2b, Rab13, and Rab20. 
Similarly, Rab13 was not observed co-localizing with Y. pestis over that observed for E. coli at the 
time points studied. However, Y. pestis co-localized with Rab2b and Rab20 at a significantly higher 
frequency than E. coli (p; ≤ 0.01 and ≤ 0.05, respectively), indicating recruitment of both Rab 
proteins to the YCV by 80 min post infection. To determine if Y. pestis actively recruited Rab2b and 
Rab20 to the YCV, macrophages were infected with PFA-fixed Y. pestis. Similar to E. coli, no PFA-
fixed Y. pestis was observed at 10 h post infection. As with both E. coli and live Y. pestis, Rab13 
did not co-localize with PFA fixed Y. pestis. Rab2b and Rab20 co-localized with PFA fixed Y. pestis 
to intermediate levels between Y. pestis and E. coli. 
Repeated attempts to overexpress Rab22a consistently resulted in cell death. Therefore, I 
was unable to define the localization of Rab22a using this method. The lack of viable cells upon 
Rab22a overexpression may suggest Rab22a trafficking within RAW264.7 is important for cell 
viability. Rab22a mediates transfer of endosomes into recycling endosomes and it is possible that 
overexpression of Rab22a causes endosomes to recycled back to the plasma membrane and thus 
fails to deliver nutrients or signaling factors from the media to important intracellular locations.  
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Figure-3-2: Rab proteins identified as essential for Y. pestis intracellular survival from de-
convoluted validation. 
RAW 264.7 macrophages were transfected with three siRNAs targeting 13 different Rab genes. 
Forty-eight hours after transfection, cells were infected with Y. pestis CO92 pCD1(-)LuxPtolC 
(●circles) or KIM D19 pCD1(+) LuxPtolC (▲triangles) (MOI of 10) and intracellular bacterial numbers 
were determined by bioluminescence (RLU) at 2 h or 10 h post-infection. Scrambled (Scr) controls 
were used as negative controls. Data is shown as the mean of percent of intracellular 
bioluminescence at 10 h post infection compared to 2 h post infection. Predicted trafficking 
pathways each identified Rab belongs to is indicated by color: red = recycling; blue = retrograde 
trafficking; purple =sorting; green = the secretory pathway; white = did not meet cutoff criteria   
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DISCUSSION 
The role of three Rab GTPases in Y. pestis intracellular survival have been previously 
investigated to date [118, 119]. Rab1b and Rab4a are recruited to the YCV early, and subsequently 
lost, while Rab11b co-localizes to the YCV throughout the course of infection [118, 119]. Rab1b 
and Rab4a are required to subvert phagosomal acidification, whereas Rab11b is not. Instead 
Rab11b targeting appears to disrupt host cell recycling by sequestration of Rab11b to the YCV 
[119]. Moreover, we also showed that targeting and sequestration of Rab11b by Y. pestis impacts 
the transition of the YCV into a spacious vacuole, and Rab11b is required for autophagy, so that 
targeting of Rab11b may link Y. pestis to autophagy through the host cell recycling pathway during 
infection [119, 127, 130]. Recruitment/sequestration of Rab GTPases by Y. pestis may be mediated 
by bacterial effector proteins that modify GTP to GDP, or vice versa transitions, ability to occur. 
Alternatively, Rab GTPase insert into membranes can be altered via prenyl group modifications. 
Pathogenic bacteria commonly use these modifications to avoid degradation by macrophages 
[239], but whether such modifications occur in the context of Y. pestis infection have yet to be 
explored.  
Here I have expanded on our understanding of the role of Rab proteins in Y. pestis 
pathogenesis by using a Rab specific RNAi screen to identify those Rab GTPases required for 
intracellular survival. All screens require an established criteria to identify hots that have the 
greatest impact on the observed phenotype. In this case, we used a cutoff of >50% decrease in Y. 
pestis intracellular survival. It is possible that the Rab GTPases approaching a 50% reduction of 
intracellular survival may also contribute to Y. pestis intracellular survival and YCV biogenesis could 
be considered as areas for future study. However, we focused on those Rab proteins that when 
knocked down, individually had the greatest impact on Y. pestis intracellular survival. Specifically, 
I demonstrated that six Rab proteins in addition to Rab1b, 4a, and 11b are required for Y. pestis 
intracellular survival. Four of these Rab GTPases (Rab2, 20, 23, 40b) were also identified as 
potential hits in a previous whole genome pooled siRNA screen, but two (Rab13 and 22a) did not 
meet cutoff criteria in the original screen [119]. The use of a smaller format (39 versus >17,000 
genes) and deconvolution for secondary validation may have allowed us to identify hits that were 
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missed in the original screen. Three of these identified Rab targets (Rab13, 22a, and 23) have 
been linked to the host cell recycling pathway [253-255], which supports our previous study 
demonstrating that subversion of this pathway is an important step in avoiding killing by 
macrophages [119]. However, the other three Rab proteins have been previously suggested to be 
involved in the trafficking of the sorting endosome (Rab20), the secretory pathway (Rab40b), and 
retrograde trafficking (Rab2b) [256-258]. The importance of these Rab GTPases for intracellular 
survival suggest 1) pathways other than the recycling pathway are important for subversion of 
phagosomal maturation and formation of the YCV by Y. pestis, or 2) these Rab GTPases function 
within the recycling pathway, but their contributions have not been defined to date. 
Upon phagocytosis, phagosomes enter the cells as sorting endosomes, which can traffic 
through either the phagosome maturation pathway or the recycling pathway, depending on cargo 
and subsequent association with downstream Rab GTPases. Rab20 has been shown to associate 
with the early endosome but not with late phagosomes [256, 259, 260]. In fact, retention of Rab20 
on the early endosome prolongs retention of Rab5 (another Rab associated with endosome sorting 
[260]) and delays phagosome maturation and lysosomal fusion, indicating that Rab20 is a key 
regulator of phagosome maturation [256, 259]. During Y. pestis infection, I showed that Rab20 co-
localized with the YCV within 20 min post-infection, and was retained over the course of infection. 
This was significantly different from E. coli, which did not appear to associate with Rab20 after 20 
min post-infection. These data indicate that Y. pestis artificially retains Rab20 to the YCV, resulting 
in stalling phagosomal maturation, and perhaps allowing for subsequent entry in the recycling 
pathway. Rab20 has only been reported previously in the context of Mycobacterium infection, and 
has been implicated as a mechanism of restricting M. tuberculosis growth [261]. Schnettger et al. 
have shown that M. tuberculosis can rupture phagosomes to acquire nutrients in the host cytosol 
[261]. To prevent access to the cytosol, the host cell maintains an intact vacuole membrane through 
a Rab20 dependent mechanism [261]. Therefore, similar to autophagy, Rab20 appears to be 
detrimental for bacteria that access the cytosol. Moreover, these data support that Y. pestis remains 
in an intact vacuole and does not need to directly access the cytosol to survive within macrophages. 
Early retention of Rab20 on the YCV suggests that it may be key for Y. pestis to avoid phagosome 
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acidification and lysosomal fusion, which should be directly tested in the future. Moreover, the 
potential role of Rab20 in autophagosome formation should be explored. 
 
Figure 3-3: Rab2b, Rab13, and Rab20 co-localization in RAW264.7 macrophages. 
RAW264.7 macrophages expressing indicated Rab-GFP proteins were infected with live Y. pestis 
CO92 pCD1(-) pGEN222::mCherry (Yp) (MOI 5), PFA-killed Y. pestis CO92 pCD1(-) 
pGEN222::mCherry (Killed) (MOI 5), or E. coli K-12 pGEN::mCherry (Eci) (MOI 20) (n=3) 
Frequency of co-localization of bacterium-containing vacuoles with transfected (A) Rab2b-EGFP 
(B) Rab13-EGFP, or (C) Rab20-EGFP Yp = Y. pestis; Killed = PFA fixed Y. pestis; Ec = E. coli. (D) 
Representative images of RAW264.7 macrophages transiently transfected with pEGFP-Rab 
(green) and co-infected with Y. pestis CO92 pCD1(-) pGEN222::mCherry. One-way ANOVA with 
Tukey’s posthoc test was performed, and the results are indicated as follows: ns, not significant; *, 
P ≤ 0.05; **, P ≤ 0.01.   
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An essential process for maintaining membrane balance is the return of membrane from 
the golgi to the endoplasmic reticulum (ER) mediated by Rab2b, termed retrograde trafficking [262] 
[258]. Rab2b has also been linked to transport of exosomes out of the cell, which may indicate that 
there is more to be understood regarding the functions of Rab2b [263]. My data shows that unlike 
Rab20 which was observed to co-localize with YCVs by 20 min post-infection, Rab2b was recruited 
to the YCVs containing both live and PFA-fixed Y. pestis, by 80 min post-infection and retained for 
the duration of the infection. The co-localization to Y. pestis was significantly greater than that 
observed for E. coli, which did not appear to co-localize with Rab2b at 80 min post infection. These 
data indicate that Y. pestis infection induces recruitment of Rab2b to the YCV, which may function 
as a way for Y. pestis to recruit nutrients/membrane to the YCV for survival and replication. The 
only bacterium reported to interact with Rab2b is Brucella abortus, which targets Rab2b via the 
effector protein RicA [243], and modulates the Brucella containing vacuole into an ER like 
compartment [264]. Interestingly, silencing of Rab2b leads to diminished intracellular growth of B. 
abortus [264], similar to what is observed for Y. pestis. Acquisition of Rab2b by the YCV suggests 
that it may be a way for Y. pestis to directly alter phagosomal maturation or acquire 
nutrients/membrane, which should be explored in the future. 
Interestingly, similar levels of Rab20 and Rab2b were observed on vacuoles containing 
live Y. pestis and killed Y. pestis vacuoles. The lack of difference between the live and PFA-fixed 
samples is unusual, as we previously showed that Rab1b, 4a, and 11b recruitment to the UCV was 
dependent on live bacteria. This suggests that some factor conserved through fixation of Y. pestis, 
potentially a surface exposed ligand not shared with E. coli such as Ail, Pla, or another moiety, may 
impact the vesicular trafficking events leading to Rab2b and Rab20 co-localization. Additionally, 
active protein production may not be required for Rab20 retention and Rab2b recruitment. This 
observation may instead indicate that the bacterial factors responsible, are generated before 
macrophage interactions. Finally, it may also suggest that the method of entry into the cell may 
contribute to downstream trafficking events, which will be discussed in greater detail in Chapter 5.  
The recycling pathway is commonly targeted by pathogens as a way to avoid 
phagolysosomal maturation and degradation [245, 265-267]. Previously I discussed how Rab20 
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delivers endosomes into the recycling pathways. Similarly, Rab13 is involved in delivering 
membranes from the Golgi to the recycling pathway [253]. Rab13 was not observed to be localized 
to the YCV or E. coli. Although Rab13 does not appear to be directly associated with the YCV, the 
phenotype observed upon silencing of Rab13 using siRNA may be due to an impact on host cell 
recycling apart from direct localization. Previously we published that Y. pestis stalls the recycling 
pathway likely through sequestration of Rab11b, potentially via a bacterial effector protein that 
recruits and retains Rab11b on the YCV; as overexpression of Rab11b restores recycling. Silencing 
of Rab11b expression does not result in Y. pestis death, but rather in the inability of Y. pestis to 
replicate, as Y. pestis remains at 10 h post infection without being degraded or replicating [119]. 
An alternative possibility for why Rab13 is important for Y. pestis intracellular survival, but does not 
localize to the YCV may attributable to interaction with Rab11b vesicles upstream of Y. pestis 
interception, thus indirectly contributing to Y. pestis survival by supplying membrane to the Rab11b 
dependent pathway. To date, exploitation of Rab13 has not been demonstrated as a host factor 
required for establishment of pathogen containing vacuoles. However, L. pneumophilia encoded 
LepB, a Rab1 GAP, is speculated to function as a GAP for additional Rab proteins including Rab13, 
although this has not been shown to occur in vivo [268]. One caveat that warrants consideration is 
that Rab13 interactions may be transient and thus missed in this analysis. Additional time points, 
or the use of a constitutively active form of Rab13 may help to identify whether transient Rab13 
localization occurs. To better understand how Rab13 contributes to Y. pestis intracellular survival, 
further work is needed to evaluate whether Rab13 is critical for avoiding degradation or if it 
contributes to formation of the spacious YCV and replication. 
Rab22a delivers endosomes to the slow recycling pathway, known to be important for Y. 
pestis survival [269-271]. Moreover, knockdown of Rab22a inhibits the return of transferrin through 
the slow recycling pathway, which we have previously is inhibited by Y. pestis infection of 
macrophages [119, 254]. Therefore, I formed the hypothesis that Rab22a is recruited by Y. pestis 
to the YCV in order to inhibit phagosomal maturation and divert to the slow recycling pathway 
instead. This would be similar to how M. tuberculosis and A. phagocytilim recruit Rab22a to their 
vacuoles in order to avoid degradation [113, 266, 272]. Although I was unable to determine if 
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Rab22a is localized to the YCV using an overexpression construct, I speculate that Rab22a 
localizes to the YCV early during infection, which could be tested using a Rab22a antibody to assay 
endogenous Rab22a localization to the YCV. Additionally, the activity of Rab22a independent of 
localization relative to the YCV should be explored, such as the impact of Rab22a knockdown on 
acidification, induction of autophagy, and formation of the spacious YCV. 
In conclusion, I have shown eight Rab GTPases, two of which were not identified by the 
Connor et al. genome wide screen, are important for Y. pestis intracellular survival within 
macrophages [119]. Moreover, I have shown that Rab2b and Rab20 are recruited to the YCV early 
during infection, while Rab13 is not. Defining the role of these Rab GTPases in avoidance of 
phagosome acidification and YCV maturation, in addition to defining the role of the other Rab 
GTPase screen hits will be important for understand how Y. pestis survives, replicates, and 
escapes from macrophages. In so doing, a clearer picture of how Y. pestis causes disease in the 
mammalian host will become evident. 
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REDUNDANT AND COOPERATIVE ROLES FOR YERSINIA PESTIS YOP 
EFFECTORS IN THE INHIBITION OF HUMAN NEUTROPHIL EXOCYTIC 
RESPONSES REVEALED BY GAIN-OF-FUNCTION APPROACH1 
                                                     
1 Pulsifer AR, Vashishta A, Reeves SA, Wolfe JK, Palace SG, Proulx MK, Goguen J, Bodduluri 
SR, Haribabu B, Uriarte SM, Lawrenz MB. 2020. Redundant and cooperative roles for Yersinia 
pestis Yop effectors in the inhibition of human neutrophil exocytic responses revealed by gain-of-
function approach. Infect Immun 88:e00909-19.1 PubMed PMID: 31871100. 
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INTRODUCTION 
Plague is the human disease caused by infection with the bacterial pathogen Yersinia 
pestis [1]. Depending upon the route of inoculation, plague can manifest in three forms [1]. Primary 
bubonic, pneumonic, or septicemic plague arises when bacteria are inoculated into the skin, lungs, 
or bloodstream, respectively. Upon infection with Y. pestis, mean time to death without medical 
intervention can range from 3 days for primary pneumonic or septicemic plague to 7 days for 
bubonic plague. A hallmark of Y. pestis infection is the lack of inflammation during early stages of 
colonization. During pneumonic plague in mice, a minimal inflammatory response is observed for 
the first 24 to 36 h of infection [37, 221, 273, 274]. Beginning at ~48 h post-infection, the 
inflammatory response to Y. pestis changes, resulting in a significant increase in inflammatory 
mediators, including monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor alpha 
(TNF-α), interleukin 12p70 (IL-12p70), gamma interferon (IFN-γ), and IL-6 [37, 221, 273, 274]. This 
coincides with an influx of immune cells, especially neutrophils, into the lungs, resulting in a rapid 
pneumonia [37, 221, 273, 274]. Similarly, inflammation is delayed in bubonic plague and does not 
occur until after Y. pestis has begun to proliferate in the draining lymph node and disseminate [3, 
4, 36]. The ability of Y. pestis to actively inhibit innate immune responses is a key virulence 
mechanism for Y. pestis [36, 37, 147, 273-275]. Normally, neutrophils are recruited in response to 
a variety of stimuli derived from damaged or activated host cells via damage-associated molecular 
patterns (DAMPs), cytokines, chemokines, or complement products [152, 231, 276]. Microbial 
components, such as lipopolysaccharide, peptidoglycan, or N-formylmethionine-leucyl-
phenylalanine peptides (fMLF), known as pathogen-associated molecular patterns (PAMPs), can 
also stimulate the recruitment of neutrophils [149]. Upon stimulation, neutrophils traverse the 
vasculature to reach the site of infection. Upon arrival at the site of infection, neutrophil antimicrobial 
responses are multifactorial and are comprised of phagocytosis, induction of the respiratory burst, 
degranulation, and release of neutrophil extracellular traps (NETs) [149]. Combined efforts from 
each of these responses make neutrophils very adept at killing microorganisms. Phagocytosis is 
important for clearing many bacterial infections, although some pathogens have acquired virulence 
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factors that inhibit uptake by neutrophils [165, 277]. In such situations, neutrophils rely upon 
extracellular release of antimicrobial mechanisms to effectively clear the infection. 
One mechanism utilized by neutrophils to combat extracellular pathogens is the release of 
antimicrobial cargo contained in preformed granules (a process referred to as degranulation or 
graded exocytosis) [153]. Degranulation occurs in a regulated manner to coordinate release or 
modification of cytokines, chemokines, and signaling ligands/receptors to facilitate neutrophil 
transmigration and chemotaxis, with release of antimicrobial components that can directly restrict 
pathogen growth. Neutrophils contain four different granule subtypes, and mobilization of each 
granule is tightly controlled and dependent on the intensity of stimulation to coordinate functional 
responses [278]. Neutrophil degranulation is hierarchical, with secretory vesicles being the first 
subtype to undergo exocytosis, followed by gelatinase granules. Degranulation of specific and 
azurophilic granules, both loaded with toxic antimicrobial cargo, is more limited and requires 
stronger stimulation to promote granule mobilization [149]. Tightly graded control of granule release 
ensures that contents are released at the correct location to diminish collateral damage to the host. 
The ability of neutrophils to mediate inflammatory responses has become more 
appreciated [279]. Neutrophils release a variety of cytokines and chemokines, as well as other 
immune modulatory factors that contribute to the cellular communication network during 
inflammation [38, 280]. One of the most potent modulators released by neutrophils is leukotriene 
B4 (LTB4). Not only is it important for recruitment of additional neutrophils to the site of infection 
[181, 190, 281], but LTB4 also enhances the antimicrobial responses of both neutrophils and 
macrophages, including phagocytosis, respiratory burst, degranulation, and the release of 
inflammatory cytokines [196, 198, 203, 205, 209]. Importantly, LTB4 production is not dependent 
on transcriptional regulation [195], and is therefore produced more rapidly than other 
chemoattractants, such as IL-8. Due to the rapidity of LTB4 production, it is pivotal in mounting a 
swift inflammatory response [198, 202, 208, 209, 282]. Moreover, release of LTB4 is independent 
of degranulation [194], suggesting that regulation of LTB4 release also differs from degranulation. 
Although neutrophils are extremely capable of restricting microbial colonization, Y. pestis 
encodes a variety of virulence factors to evade recognition and killing by neutrophils [43, 48, 53, 
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166, 283]. The Ysc type 3 secretion system (T3SS) secretes seven Yersinia outer protein (Yop) 
effectors directly into host cells and is paramount for inhibition and evasion of neutrophil responses 
[40, 147, 166, 221, 226, 284-286]. Moreover, several in vivo studies have demonstrated that 
neutrophils are the primary cell type that Y. pestis interacts with during early stages of infection [42, 
43, 221]. Once injected into neutrophils, Y. pestis Yop effectors interact with specific host factors 
to disrupt multiple host signaling pathways. YpkA, YopE, YopH, and YopT disrupt the actin 
cytoskeleton via interactions with host Rac, Rho, and focal adhesion complex proteins [76, 77, 81-
83, 225, 226, 285-295]. YopH has also been shown to inhibit host cell calcium flux [81, 296], while 
YopJ inhibits mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) 
cascades [86, 224, 229, 284, 296]. Together, these Yop effectors have been shown to effectively 
inhibit neutrophil phagocytosis, respiratory burst, and cytokine/chemokine release [86, 166, 224, 
284]. Importantly, the Yop translocon pore and effects of Yop effectors on host proteins can trigger 
inflammasome activation, which should lead to inflammatory responses [91, 297-299]. However, 
YopM and YopK function to inhibit inflammasome activation and subsequent inflammatory 
responses [91, 93, 97, 297, 299-302]. Together, the Yop effectors allow Y. pestis to actively inhibit 
the inflammatory response. 
Recently it was shown that Yersinia pseudotuberculosis inhibits neutrophil degranulation 
in a T3SS-dependent manner, which was dependent on the actions of YopE and YopH [233]. Here, 
we show T3SS-dependent inhibition of neutrophil degranulation by Y. pestis, as well as roles of 
both YopE and YopH in inhibition. However, using a gain-of-function approach with a library of Y. 
pestis strains only expressing one Yop effector, we were able to identify additional Yop effectors 
contributing to inhibition of degranulation that have not been previously observed. Moreover, we 
show for the first time that Y. pestis actively inhibits production of LTB4 by human neutrophils, and 
we identify the Yop effectors contributing to this inhibition. 
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RESULTS 
Y. pestis inhibits neutrophil degranulation in a T3SS-dependent manner. 
Degranulation is a highly regulated but quick response that generally occurs within minutes 
after encountering a stimulus. Multiple studies have provided an understanding of the contents of 
the different granules that are released during degranulation (e.g., albumin is released during 
degranulation of secretory vesicles; gelatinase is released during degranulation of gelatinase 
granules), and the increased expression of receptors displayed on the neutrophil cell surface upon 
granule fusion with the plasma membrane (e.g., CD66b is displayed after degranulation of specific 
granules; CD63 is displayed after degranulation of azurophilic granules) (reviewed by Cowland and 
Borregaard [167]). Importantly, using these markers, degranulation of each granule subtype in 
response to different stimuli can be reliably monitored. Recently, it has been shown that Y. 
pseudotuberculosis inhibits degranulation by human neutrophils [233]. To determine whether Y. 
pestis similarly inhibits degranulation, human neutrophils were infected with Y. pestis CO92 or with 
a strain lacking the pCD1 plasmid encoding the Ysc T3SS [Y. pestis CO92 T3(-)]. At a multiplicity 
of infection (MOI) of 10 or 100, minimal, if any, release of the four granule subtypes was observed 
in response to Y. pestis CO92 (Figure 3-1). Similarly, at an MOI of 10, infection with Y. pestis CO92 
T3(-) did not result in degranulation. However, at an MOI of 100, Y. pestis CO92 T3(-) caused 
significant release of all four granule subtypes compared to infection with Y. pestis CO92 (Figure. 
3-1 and Figure 3- 2A and B). Surprisingly, using an MOI 10-fold higher, granules are not released 
in response to infection with Y. pestis CO92 T3(-), indicating the T3SS is a potent inhibitor of granule 
release. Infection with Y. pestis KIM derivative with and without the pCD1 plasmid recapitulated the 
phenotypes observed for Y. pestis CO92 and CO92 T3(-), respectively. Together, these data, and 
data from a T3 effector-less mutant that produced the same phenotype as T3- (data not shown), 
indicate that degranulation is inhibited by Y. pestis in a T3SS-dependent manner.  
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Cooperative inhibition of neutrophil degranulation by Yop effectors revealed through gain-of-
function approach. 
The Ysc T3SS delivers seven effector proteins into targeted host cells [303]. To determine 
if a single Yop effector is responsible for inhibiting neutrophil degranulation, human neutrophils 
were infected with a library of Y. pestis KIM1001 strains containing in-frame deletions of one yop 
gene (Table 2-1). While Y. pestis is able to inhibit release of all four granule subtypes (Figure 4-1), 
specific and azurophilic granules contain most of the antimicrobial components produced by 
neutrophils, and are typically released at the site of infection, where neutrophils would come into 
direct contact with Y. pestis. We therefore focused on the ability of Y. pestis Yop effectors to inhibit 
release of these two granule subtypes. Moreover, comparing the expression of degranulation 
markers after incubation with Y. pestis T3(-) for 30 and 60 min indicated that degranulation peaked 
by 30 min post-infection (Figure 4-2C and D). Therefore, degranulation was monitored at 30 min 
post-infection for subsequent experiments. As shown in Figure 3-3, infection with the Y. pestis 
KIM1001 T3(-) strain resulted in significant release of both specific and azurophilic granules 
compared to infection with mutants lacking any single yop gene. Each of the individual deletion 
mutants retained the ability to inhibit release of either granule, with surface expression of 
degranulation markers similar to that observed for Y. pestis KIM1001 (Figure 4-3). Similar results 
were observed with individual yop deletion mutants in the Y. pestis CO92 background (data not 
shown). These data suggest that more than one Yop effector protein is able to inhibit neutrophil 
granule release (i.e., functional redundancy in the system). 
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Figure-4-1: Y. pestis inhibits degranulation in a T3SS-dependent manner. 
Human neutrophils (4x106) were infected with Y. pestis CO92 or Y. pestis KIM1001 with or without 
the pCD1 plasmid encoding the T3SS (T3+ or T3-, respectively) at indicated multiplicities of 
infection (MOIs) (10 or 100). Degranulation was measured after 30 min of infection for (A) secretory 
vesicles and (B) gelatinase, (C) specific, and (D) azurophilic granules. UT, untreated cells. Mean ± 
standard error of the mean (SEM) from 5 biologically independent experiments. One-way analysis 
of variance (ANOVA) with Sidak’s post hoc test; *, P<0.05; ***, P<0.001; ****, P<0.0001. 
Representative flow cytometry histograms for specific and azurophilic granules are shown in Figure 
4-2. 
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Figure-4-2: Degranulation of specific and azurophilic granules peaks by 30 min post-
infection. 
Human neutrophils (4x106) were infected with Y. pestis CO92 with or without the pCD1 plasmid 
encoding the T3SS (T3+ or T3-, respectively); MOI of 100. Degranulation of (A and B) specific 
and (C and D) azurophilic granules was measured 30 min and 1 h post-infection by flow 
cytometer. (A) and (C) Representative histogram for one experiment from (B) and (D) 
respectively. For (B) and (D) Mean ±SEM from 4 biologically independent experiments. One-way 
ANOVA with Sidak’s post-hoc; ns = not significant. UT = untreated cells. 
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Figure-4-3: Deletion of individual Yop effector proteins does not alter neutrophil 
degranulation response to Y. pestis infection. 
Human neutrophils (4x106) were infected with Y. pestis KIM1001 with or without the pCD1 plasmid 
encoding the T3SS (T3+ or T3-, respectively) or with strains lacking ypkA (ΔA), yopE (ΔE), yopH 
(ΔH), yopJ (ΔJ), yopK (ΔK), yopM (ΔM), or yopT (ΔT); MOI=100. Degranulation was measured 
after 30 min of infection for (A) specific or (B) azurophilic granules. Mean ± SEM from 5 biologically 
independent experiments. One-way ANOVA with Dunnett’s post hoc test to T3-; ****, P<0.0001. 
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Recently, Palace et al. developed a library of Y. pestis strains that only express one Yop 
effector [229]. This library allows for the study of individual Yop effectors without the presence of 
the other six, which could confound data interpretation due to phenotypical masking by functionally 
redundant proteins. To determine whether individual Yop effectors inhibit degranulation, 
neutrophils were infected with strains from this library and monitored for exocytosis of specific and 
azurophilic granules (Figure 4-4). While strains expressing YopE, YopH, or YopT trended toward 
decreased specific granule exocytosis, none of the mutants demonstrated statistically significant 
decreases in exocytosis compared to the T3(-) strain (Figure 4-4A). Similar trends were observed 
for exocytosis of azurophilic granules for strains expressing YopE and YopH, but surprisingly, the 
strain expressing only YopT caused increased release of azurophilic granules (Figure 4-4B). These 
data indicate that while there is functional redundancy for inhibiting degranulation by neutrophils, 
the effector proteins also work in a cooperative manner during Y. pestis infection to effectively 
inhibit exocytosis of specific and azurophilic granules. 
YopE, YopH, YopJ, and YpkA act cooperatively to inhibit degranulation of specific and azurophilic 
granules. 
To determine which Yop effectors act cooperatively to inhibit degranulation, a coinfection 
approach with two strains of Y. pestis expressing different individual Yop effectors was employed. 
Neutrophils were infected with a 1:1 mixture of two Y. pestis strains, each expressing different Yop 
proteins (final MOI is 100; MOI of 50 for each strain). Exocytosis of specific and azurophilic granules 
was compared to that of cells infected with Y. pestis KIM1001 T3(-) or a 1:1 mixture of Y. pestis 
KIM1001 and Y. pestis KIM1001 T3(-). As expected, coinfections with Y. pestis KIM1001 expressing 
all of the Yop proteins significantly decreased exocytosis of both specific and azurophilic granules 
compared to infection with only Y. pestis KIM1001 T3(-) (Figure 4-5 and 4-6).  
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Figure-4-4: Individual Yop effector proteins are unable to completely inhibit degranulation. 
Human neutrophils (4x106) were infected with Y. pestis KIM1001 with or without the pCD1 plasmid 
encoding the T3SS (T3+ or T3-, respectively) or with strains expressing only ypkA (+A), yopE (+E), 
yopH (+H), yopJ (+J), yopK (+K), yopM (+M), or yopT (+T); MOI=100. Degranulation was measured 
after 30 min of infection for (A) specific or (B) azurophilic granules. Mean SEM from 5 biologically 
independent experiments. One-way ANOVA with Dunnett’s post hoc test to T3+: **, P<0.01; ****, 
P<0.0001. 
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Figure 4-5: At least two Yop effector proteins are required to fully inhibit specific granule 
release. 
Human neutrophils (4x106) were co-infected with Y. pestis KIM1001 with or without the pCD1 
plasmid encoding the T3SS (T3+ or T3-, respectively) or with strains expressing only ypkA (+A), 
yopE (+E), yopH (+H), yopJ (+J), yopK (+K), yopM (+M), or yopT (+T) mixed at a 1:1 ratio with 
strains expressing only (A) yopH (+H), (B) yopE (+E), (C) yopJ (+J), or (D) ypkA (+A); MOI of each 
strain was 50 for a combined MOI of 100. Specific granule release was measured after 30 min of 
infection. Mean ± SEM from 5 biologically independent experiments. One-way ANOVA with 
Dunnett’s post hoc test. Gray bars are significantly different than T3- (P<0.05); purple bars are 
significantly different from T3+/T3-.  
67 
 
 
Figure 4-6: At least two Yop effector proteins are required to fully inhibit azurophilic granule 
release. 
Human neutrophils (4x106) were co-infected with Y. pestis KIM1001 with or without the pCD1 
plasmid encoding the T3SS (T3+ or T3-, respectively) or with strains expressing only ypkA (+A), 
yopE (+E), yopH (+H), yopJ (+J), yopK (+K), yopM (+M), or yopT (+T) mixed at a 1:1 ratio with 
strains expressing only (A) yopH (+H), (B) yopE (+E), (C) yopJ (+J), or (D) ypkA (+A); MOI of each 
strain was 50 for a combined MOI of 100. Azurophilic granule release was measured after 30 min 
of infection. Mean ± SEM from 5 biologically independent experiments. One-way ANOVA with 
Dunnett’s post hoc test. Gray bars are significantly different than T3- (P<0.05); purple bars are 
significantly different than T3+/T3- (P<0.05); hatched bars are not significantly different than T3- or 
T3+/T3-.  
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Co-infection with two strains expressing only one Yop protein revealed that cooperative actions by 
four effectors were sufficient to inhibit degranulation of both specific and azurophilic granules. 
Coinfection with strains expressing YopH and YopE, YopH and YpkA, YopH and YopJ, or YopE 
and YopJ was sufficient to inhibit degranulation of both granules to levels similar to coinfection with 
Y. pestis KIM1001 and Y. pestis KIM1001 T3(-) (Figure 4-5 and 4-6). Coinfection with YopH and 
YopK appeared to also sufficiently inhibit release of azurophilic granules. For specific granules, 
coinfection with YopH and YopK, YopH and YopT, or YopE and YopT showed intermediate 
phenotypes. Coinfection with YopT could reverse the ability of YopH and YopE to partially inhibit 
degranulation of azurophilic granules (Figure 4-6A and B), reflecting the enhanced degranulation 
previously observed in single YopT infection (Figure 4-4B). However, coinfection with YopJ or YpkA 
appeared to inhibit the YopT enhanced degranulation phenotype (Figure 4-6C and D). Together, 
these data confirm previously reported roles for YopH and YopE in inhibition of degranulation [233], 
and also revealed previously hidden contributions of YpkA, YopJ, and YopK. 
Y. pestis inhibits LTB4 response of human neutrophils. 
LTB4 is a potent chemoattractant released by neutrophils independently of degranulation, 
and it contributes to early inflammation in response to infection [181, 194]. As inhibition of 
inflammation is a hallmark of Y. pestis infection, we next asked whether Y. pestis inhibits release 
of LTB4 by human neutrophils. Neutrophils were infected with Y. pestis KIM1001 or Y. pestis 
KIM1001 T3(-), and the level of LTB4 released into the supernatant was compared to that released 
by untreated neutrophils (Figure 4-7A). Infection with Y. pestis KIM1001 did not result in significant 
release of LTB4 compared to untreated neutrophils. However, when neutrophils were infected with 
Y. pestis KIM1001 T3(-), a significant increase in LTB4 secretion was observed (Figure 4-7A; 
P<0.01). To determine if these differences in LTB4 levels were sufficient to alter chemotaxis of 
naive neutrophils, conditioned supernatants from infected neutrophils were used in a chemotaxis 
assay and compared to supernatant from untreated neutrophils (Figure 4-7B). Naive neutrophils 
exposed to buffer or fMLF, a known chemoattractant, were used as controls. The numbers of naive 
neutrophils migrating toward the conditioned supernatant from untreated and Y. pestis KIM1001-
69 
 
infected neutrophils were not significantly different. However, in direct correlation with the elevated 
levels of  
 
Figure 4-7: Y. pestis inhibits human neutrophil LTB4 response. 
Human neutrophils (4x106) were infected with Y. pestis KIM1001 with or without the pCD1 plasmid 
encoding the T3SS (T3+ or T3-, respectively); MOI=100. (A) Release of LTB4 was measured after 
30 min of infection in supernatant. (B and C) Chemotaxis of naive neutrophils in response to 
conditioned supernatant (B) without or (C) with pretreatment of the BLT1 inhibitor LY293111. (D) 
LTB4 concentrations in the supernatant or (E) cell lysates of neutrophils infected with strains 
expressing only ypkA (+A), yopE (+E), yopH (+H), yopJ (+J), yopK (+K), yopM (+M), or yopT (+T). 
Mean ± SEM from 5 biologically independent experiments. One-way ANOVA with Dunnett’s post 
hoc test. **, P<0.01; ***, P<0.001; ****, P<0.0001; ns, not significant. (D and E) Gray bars are 
significantly different than T3- (P<0.05); purple bars are significantly different from T3+/T3- 
(P<0.05); hatched bars are not significantly different from T3- or T3+/T3-.  
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LTB4 in the conditioned supernatant, significantly more neutrophils migrated toward the 
supernatant collected from cells infected with Y. pestis KIM1001 T3(-) (Figure 4-7B; P<0.01). 
Pretreatment of naive neutrophils with an inhibitor that blocks signaling through the LTB4 high-
affinity receptor BLT1 eliminated chemotaxis toward the conditioned supernatant but not toward 
fMLF (Figure 4-7C). These results indicate that the presence of LTB4 in the conditioned supernatant 
was promoting chemotaxis. 
Next, we used the library of Y. pestis mutants expressing only one Yop effector to ask 
whether individual effector proteins are sufficient to inhibit LTB4 release. In contrast to the data 
observed for inhibition of specific and azurophilic granule release, four of the seven Yop effectors 
(YpkA, YopE, YopH, and YopJ) were able to inhibit LTB4 release to levels similar to those of Y. 
pestis KIM1001 (Figure 4-7D). Moreover, infection with the strain only expressing YopT also 
substantially decreased the amount of LTB4 released from the neutrophils, although to a lesser 
degree than the other four effectors. Finally, to determine if Y. pestis infection inhibits synthesis or 
release of LTB4, intracellular levels of LTB4 from infected neutrophils were measured. Similar to the 
results observed for conditioned supernatants, significantly lower amounts of intracellular LTB4 
were detected in cells infected with Y. pestis KIM1001 and mutants expressing YpkA, YopE, YopH, 
YopJ, and YopT (Figure 4-7E). Together, these data indicate that Y. pestis actively inhibits 
synthesis of LTB4 from human neutrophils in a T3SS-dependent manner, multiple Yop effectors 
are sufficient to inhibit LTB4 synthesis, and the inhibition of LTB4 release by infected neutrophils 
negatively impacts the chemotactic activity of naïve neutrophils to respond to the infection.  
Disruption of the host cytoskeleton inhibits LTB4 release in response to Y. pestis infection. 
Although different mechanisms are used by YpkA, YopE, YopH, and YopT, all four proteins 
have been shown to affect actin cytoskeletal rearrangement in host cells [225, 285, 304-306]. 
Because of this common effect, we hypothesized that Y. pestis disruption of the actin cytoskeleton 
could inhibit LTB4 release. If true, the release of LTB4 observed during infection with Y. pestis 
KIM1001 T3(-) could be blocked by artificially disrupting the actin cytoskeleton. To test this 
hypothesis, human neutrophils were incubated with latrunculin A, a chemical inhibitor of actin 
polymerization, prior to infection with Y. pestis, and LTB4 released into the supernatant was 
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measured. As previously observed, significantly higher levels of LTB4 were secreted by neutrophils 
treated with the vehicle and infected with Y. pestis KIM1001 T3(-) than by vehicle-treated neutrophils 
infected with Y. pestis KIM1001 (Figure 4-8A; P<0.01). However, treatment with latrunculin A 
resulted in loss of LTB4 release in response to the strain lacking the T3SS, supporting that actin 
cytoskeleton disruption by Yop effectors can inhibit the LTB4 response in neutrophils. 
Disruption of MAPK signaling inhibits LTB4 synthesis in response to Y. pestis infection. 
YopJ does not directly impact the host cell cytoskeleton, but it is a potent inhibitor of MAPK 
signaling [71, 87, 307, 308]. Since MAPK signaling has been shown to control LTB4 synthesis in 
other models [71, 87, 307-312], we hypothesized that YopJ inhibition of LTB4 synthesis is mediated 
by disruption of MAPK signaling. In vitro data indicate that YopJ can interact with multiple kinases 
in this pathway, including MAP3K (e.g., the TGF-β activating kinase [TAK1]) and MAP2K (e.g., 
mitogen-activated kinase kinase 6 [MEK6]) [71, 302, 312-314]. Because TAK1 represents the 
earliest point in MAPK signaling targeted by YopJ, we tested whether treatment of neutrophils with 
a TAK1 chemical inhibitor was sufficient to inhibit LTB4 synthesis in response to Y. pestis KIM1001 
T3(-). As expected, when cells were exposed to the drug vehicle, we observed a significant increase 
in LTB4 release by neutrophils infected with Y. pestis KIM1001 T3(-) compared to that by neutrophils 
infected with Y. pestis KIM1001 (Figure 4-8B; untreated, P<0.001). However, addition of the TAK1-
specific inhibitor (5Z)-7-oxozeaenol [(5Z)-7-oxo] inhibited this response by neutrophils, and no 
difference in LTB4 concentration was observed in the supernatants of neutrophils infected with Y. 
pestis KIM1001 or Y. pestis KIM1001 T3(-) [Figure 4-8B; (5Z)-7-oxo]. TAK1 signaling is upstream 
of the MAPKs ERK and p38, but has not been shown to activate JNK in neutrophils [313]. To 
determine which MAPK was impacted by inhibition of TAK1 signaling, cell lysates from infected 
neutrophils were harvested, and the levels of phosphorylated p38 and ERK were measured by 
Western blotting. Compared to untreated neutrophils, we observed no difference in the 
phosphorylation of p38 during Y. pestis infection in the presence of the TAK1 inhibitor [Figure 4-8C 
and 4-9B; untreated versus (5Z)-7-oxo]. However, while phosphorylation of ERK was significantly 
increased in untreated cells during infection with Y. pestis KIM1001 T3(-), chemical inhibition of 
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TAK1 signaling resulted in decreased ERK phosphorylation [Figure 4-8D; (5Z)-7-oxo], indicating 
that TAK1- 
 
Figure 4-8: Inhibition of cytoskeletal rearrangement or MAPK signaling inhibits LTB4 
release. 
Inhibition of cytoskeletal rearrangement or MAPK signaling inhibits LTB4 release. Human 
neutrophils (4x106 for LatA treatment or 8x106 for Western blots) were infected with Y. pestis 
KIM1001 with or without the pCD1 plasmid encoding the T3SS (T3+ or T3-, respectively); MOI=100. 
(A) Concentration of LTB4 in supernatant from infected neutrophils with indicated Y. pestis strains 
after pretreatment with vehicle control (LatA-) or latrunculin A (LatA+) prior to infection. (B) 
Concentration of LTB4 in culture supernatants after infection with indicated Y. pestis strains after 
pretreatment with vehicle control (untreated), the TAK1 inhibitor (5Z)-7-oxozeaenol [(5Z)-7-Oxo], 
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or the ERK inhibitor U0126. (C) Phosphorylation of p38 and (D) ERK during infection with indicated 
strains after pretreatment with vehicle control (untreated), the TAK1 inhibitor (5Z)-7-oxozeaenol 
[(5Z)-7-Oxo], or the ERK inhibitor U0126. (E) Phosphorylation of ERK during infection with indicated 
Y. pestis strains. T3+, Y. pestis KIM1001; T3-, Y. pestis KIM1001 T3(-); +J, KIM1001 expressing 
only yopJ; UT, uninfected. (A and B) Mean ± SEM from 5 biologically independent experiments. 
(C, D, and E) Mean relative expression calculated from 3 biologically independent Western blots. 
One-way ANOVA with Sidak’s post hoc test. *, P<0.05; **, P<0.01; ***, P<0.001. 
 
mediated activation of LTB4 synthesis during Y. pestis KIM1001 T3(-) infection is through the ERK 
signaling pathway. To confirm that ERK signaling mediates LTB4 production in response to Y. pestis 
KIM1001 T3(-), neutrophils were treated with the ERK-specific inhibitor U0126 prior to Y. pestis 
infection. Similarly to treatment with the TAK1 inhibitor, blocking ERK signaling with U0126 inhibited 
the release of LTB4 in response to the Y. pestis KIM1001 T3(-) strain (Figure 4-8B; U0126). Western 
blot analysis confirmed that U0126 specifically inhibited ERK phosphorylation and not p38 
phosphorylation during Y. pestis KIM1001 T3(-) infection (Figure 4-8C and D and 4-9B; U0126). 
Importantly, infection with Y. pestis KIM1001 expressing only YopJ recapitulated the inhibition of 
ERK phosphorylation observed during infection with Y. pestis expressing all of the Yop effectors 
(Figure 4-8E and 4-9C), demonstrating that YopJ is sufficient to inhibit ERK signaling during Y. 
pestis infection. While inhibition of ERK signaling is sufficient to inhibit LTB4 release, the T3SS also 
inhibits phosphorylation of p38 in a non-TAK1 dependent manner (Figure 4-9A). Together, these 
data indicate that inhibition of ERK signaling in neutrophils by YopJ is sufficient to inhibit LTB4 
synthesis during Y. pestis infection. 
DISCUSSION 
Through the T3SS and other virulence factors, Y. pestis is able to actively evade and inhibit 
the mammalian innate immune response, which allows the bacterium to colonize the host [44, 102, 
303]. Previous work has demonstrated targeting of resident and arriving neutrophils by Y. pestis 
for T3SS injection, which inhibits neutrophil antibacterial mechanisms that would otherwise result 
in bacterial killing [40, 42, 43, 55, 166, 221, 222, 224, 315]. Specifically, Y. pestis has been shown 
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to inhibit phagocytosis [147, 166], reactive oxygen species production [147, 166, 284], and 
production of cytokines [224] by neutrophils. Our study further expands the understanding of how 
Y. pestis impairs the inflammatory response of host neutrophils by inhibition of neutrophil 
degranulation and LTB4 synthesis. Work in the closely related species Y. pseudotuberculosis 
demonstrated that the T3SS actively inhibits neutrophil degranulation via the contributions of YopE 
and YopH [233]. The Y. pseudotuberculosis study used adherent neutrophils, whereas we used 
neutrophils in suspension for several reasons. Adhering neutrophils causes partial activation and 
release of secretory vesicles, so that assaying secretory vesicle release would not be possible 
[316]. Furthermore, adherent neutrophils are also partially primed and more sensitive to further 
stimulus than neutrophils in suspension [212, 213, 316]. Moreover, interactions between bacteria 
and neutrophils are more random in suspension, and requiring higher MOIs to observe the same 
phenotype using adherent neutrophils [149, 317]. To understand the impact of Y. pestis infection 
on all four granule subtypes, neutrophils in suspension were used with an MOI higher than was 
used for the Y. pseudotuberculosis study [233]. 
Our data, and a recent report from Eichelberger et al. [318], demonstrate that Y. pestis also 
utilizes these two effector proteins to inhibit neutrophil degranulation. However, by using a gain-of-
function technique, we were also able to identify the contributions of YopJ and YpkA to the inhibition 
of specific and azurophilic granule exocytosis. Moreover, and importantly, we were able to show 
that multiple Yop effectors must act cooperatively to inhibit degranulation. The likely reasons YopJ 
and YpkA contributions were missed previously are because (i) four different protein combinations 
can inhibit degranulation of both specific and azurophilic granules, and (ii) while four proteins are 
involved, the bacterium requires either YopH or YopE (i.e., YopJ and YpkA cannot inhibit without 
YopE or YopH). Therefore, using a conventional loss-of-function deletion approach, a yopE yopH 
double mutant will have a phenotype, while any other double mutation combination will not, leading 
to the erroneous conclusion that YopE and YopH are redundant and sufficient to inhibit 
degranulation. These data also suggest the potential for hidden contributions of Yop effectors to 
other previously described phenotypes identified via loss-of-function mutational approaches. For 
example, while YopJ has been linked to inhibition of IL-8 by neutrophils, a yopJ mutant does not 
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release as much IL-8 as a T3SS-deficient mutant, suggesting cooperative actions by other Yop 
effectors [224]. Identification of other Yop effectors involved in inhibition could be performed using 
a similar gain-of-function approach to that described here. 
 
Figure 4-9: Quantification of p38 and ERK phosphorylation. 
Human neutrophils (8x106) were infected with Y. pestis KIM1001 with or without the pCD1 plasmid 
encoding the T3SS (T3+ or T3-, respectively); MOI = 100. (A) Mean relative expression 
phosphorylated p38 or (B) phosphorylated ERK during infection with indicated strains after pre-
treatment with vehicle control (Untreated), the TAK1 inhibitor (5Z)-7-Oxozeaenol ((5Z)-7-Oxo), or 
the ERK inhibitor (U0126). (C) Mean relative expression of phosphorylated ERK during infection 
with indicated Y. pestis strains. Y. pestis KIM1001 = T3+; KIM1001 T3(-) = T3-; KIM1001 expressing 
only yopJ =  +J; Uninfected = UT. Mean ±SEM from 3 biologically independent experiments. One-
way ANOVA with Sidak’s post-hoc; ns= not significant, *, P<0.05.  
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Previous work has shown that YopE and YpkA target Rac signaling [72, 77, 319], YopH 
targets the focal adhesion complex [285], and YopJ targets the MAPK signaling pathway [71, 86, 
87, 295, 308-310]. All three of these host factors are key nodes in signaling pathways shown to be 
integral to regulating neutrophil granule release [154, 169]. However, based on data from infections 
with single gain-of-function mutants, inhibition of one of these pathways by an individual Yop 
effector is not sufficient to inhibit degranulation. This suggests that individual signaling pathways 
may not be completely inhibited by the effector, or alternatively, that loss of signaling through one 
pathway can be compensated for in the neutrophil by signaling through the other pathways. 
While the latter hypothesis may be supported by our observation that YopE and YpkA, 
which both target the same node/pathway, are not able to inhibit degranulation, our data do not 
rule out the former, as some degree of signaling through this node may still occur during coinfection 
with the YopE and YpkA strains. To overcome this hurdle, Y. pestis evolved to inhibit all three 
signaling pathways, with inhibition of at least two being sufficient to inhibit degranulation (an 
example of cellular process redundancy [320]). Importantly, the signaling pathways affected by 
these nodes are also important for other neutrophil antimicrobial mechanisms [153, 179, 216, 321]. 
Therefore, by targeting these host factors, Y. pestis is able to simultaneously inhibit multiple arms 
of the neutrophil response to subvert the functions of host neutrophils. 
While the contributions of YopH, YopE, YpkA, and YopJ to inhibition of degranulation were 
conserved for specific and azurophilic granules, coinfections with YopH and YopK only appeared 
to inhibit the release of azurophilic granules. Based on the described function of YopK, which is 
thought to primarily regulate the translocation of other Yop effectors into the host cell to evade 
inflammasome recognition [93], we were surprised that YopK enhanced inhibition during 
coinfection with YopH. While YopK is thought to act as a gatekeeper, regulating the translocation 
of the other effectors from inside the cell [92], it has not been shown to regulate the transport of 
effectors through the T3SS of other bacteria during coinfection of a cell (i.e., trans-
complementation). While it is possible that during coinfection YopK is trans-regulating the levels of 
YopH translocated by other bacteria, it is not clear how this would enhance inhibition of 
degranulation of azurophilic granules or why this would not also impact specific granules. 
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Alternatively, it is possible that YopK has other yet-to-be defined functions in the host cells, beyond 
its role as a gatekeeper, that contribute to this phenotype, and future studies with YopK should be 
open to this possibility. 
While YopE, YopH, YpkA, and YopT disrupt the host actin cytoskeleton, translocation of 
YopT by itself resulted in a phenotype that differed from the other three, enhanced azurophilic 
granule exocytosis (Figure -3-6B). Johnson et al. described Gem-interacting protein (GMIP), 
through RhoA GAP activity, controlling actin remodeling around the secretory Rab27a-JCF1 
positive subpopulation of azurophilic granules to facilitate exocytosis [171]. Inhibition of actin 
polymerization by regulation of RhoA and ROCK activity releases the barrier that limits granule 
exocytosis [169]. Therefore, inactivation of RhoA by YopT is likely responsible for this phenotype. 
However, since this phenotype is specific for YopT, this suggests that YopT targeting of RhoA is 
spatially or temporally distinct from that of the other Yop effectors, that YopE and YpkA do not 
target RhoA during neutrophil infection, or that different mechanisms of RhoA inactivation by 
individual Yop effectors (e.g., protease cleavage versus GAP activity) may result in different 
degrees/rates of inactivation. Importantly, the action of the other Yop effectors inhibits this 
enhanced degranulation response in the context of wild-type (WT) Y. pestis infection to protect the 
bacterium from release of azurophilic granules. 
Individually, YpkA, YopE, YopH, YopJ, and YopT all appear to be sufficient to inhibit LTB4 
synthesis. Synthesis of LTB4 requires activation and re-localization of the enzyme 5-lipooxygenase 
(5-LO) to a membrane such as the nucleus or endoplasmic reticulum or to recently described 
cytosolic structures called lipidosomes [190, 322, 323]. In this active state, 5-LO rapidly converts 
arachidonic acid to LTA4, which is followed by conversion to LTB4 by LTA4 hydrolase [189, 190]. 
The mechanisms leading to 5-LO translocation are not well defined. Moreover, whether the rate-
limiting step for initiation of LTB4 synthesis is re-localization to membranes or bringing 5-LO in 
proximity to 5-LO activating protein (FLAP) is still uncertain. However, 5-LO is known to associate 
with two actin-interacting proteins, growth factor receptor-bound protein 2 (Grb2) and coactosin-
like protein (CLP) [324]. These interactions suggest that 5-LO translocation or interactions with 
FLAP require the actin cytoskeleton. This is further supported by our data, as four out of the five 
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effectors that inhibit LTB4 synthesis also disrupt the actin cytoskeleton. Moreover, treatment with 
the actin inhibitor latrunculin A also inhibited LTB4 synthesis in response to Y. pestis T3(-). However, 
it is possible that individual effectors may inhibit the synthesis process at different steps, and 
identifying which steps are inhibited during Y. pestis infection is a future direction of our studies. 
In addition to disruption of the host cytoskeleton, we have shown that Y. pestis is able to 
inhibit LTB4 via YopJ disruption of ERK signaling. While YopJ inhibition of MAPK signaling has 
been extensively studied in the context of macrophages [71, 87], to our knowledge, this is the first 
time YopJ inhibition of MAPK phosphorylation has been confirmed in neutrophils. Specifically, our 
data demonstrates that both ERK and p38 phosphorylation are inhibited during Y. pestis infection 
of neutrophils in a T3SSdependent manner and that inhibition of TAK1-ERK signaling axis by YopJ 
is sufficient to inhibit LTB4 synthesis (Figure 3-8). In primary human neutrophils, TAK1 can 
differentially signal through ERK and p38, and phosphorylation of these MAPKs is dependent on 
the stimulus encountered by the neutrophils [313]. For example, stimulation of neutrophils with 
lipopolysaccharide (LPS) results in TAK1-mediated phosphorylation of both ERK and p38, while 
stimulation with granulocyte-macrophage colony-stimulating factor (GM-CSF) results in TAK1-
mediated regulation of the MEK/ERK axis [102]. Importantly, signaling via the TAK1-ERK pathway 
has also been shown to mediate LTB4 synthesis by neutrophils in response to other 
chemoattractant factors [102], supporting our findings that targeting ERK signaling by YopJ 
contributes to inhibition of LTB4 synthesis during Y. pestis infection. Importantly, MAPK signaling 
not only regulates LTB4 synthesis in neutrophils but also induction of the respiratory burst, 
production of cytokines, and degranulation [159, 162, 170, 188, 313, 325]. Therefore, targeting of 
MAPK signaling by YopJ and inhibition of TAK1-ERK-mediated signaling allows Y. pestis to disrupt 
many arms of the neutrophil response simultaneously. 
In conclusion, Y. pestis is well adapted to surviving within the hostile host environment. 
Through this work, we found that neutrophils can only undergo granule exocytosis in response to 
Y. pestis infection when the T3SS is absent. In addition, the data presented here support previously 
described roles for YopE and YopH in inhibition of degranulation [233], while uncovering previously 
unidentified roles for YopJ and YpkA, which cooperatively work with YopE and YopH. Given these 
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new data, we can also update the current model for inhibition of degranulation by Y. pestis to 
include the information that the bacterium needs to inhibit two of three signaling pathways to 
completely inhibit neutrophil degranulation. Moreover, Y. pestis also inhibits the synthesis of the 
potent chemoattractant LTB4. Without LTB4, neutrophil recruitment to the site of infection would be 
impaired. Moreover, as LTB4 also stimulates macrophages toward enhanced phagosomal 
degradation of microorganisms [198] and promotes dendritic cell activation of T-cell responses 
[197, 326, 327], both of these important mechanisms to coordinate early antimicrobial responses 
by host innate immune cells are likely impaired during Y. pestis infection. Inhibition of neutrophil 
degranulation and LTB4 production likely contributes to Y. pestis subverting the innate immune 
response and maintaining a non-inflammatory host environment early during infection. 
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ADDITIONAL OBSERVATIONS, DISCUSSION, AND FUTURE DIRECTIONS 
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RESEARCH SUMMARY 
The human immune system relies upon an interplay between cell types to produce a finely 
tuned response to microbial infection. The keystone cells mediating the initial response to infection 
are innate immune cells, namely macrophages and neutrophils [165, 181]. Y. pestis has adapted 
to survive in the hostile mammalian host through subversion and inhibition of many innate immune 
cell responses [39, 41, 70, 166, 224]. Early inhibition of inflammatory signals maintains an 
environment permissive to Y. pestis replication [36, 40, 146, 274]. Understanding how Y. pestis 
subverts and manipulates innate immune cell responses, sheds light on how the early non-
inflammatory response is maintained, allowing Y. pestis to survive and replicate within the host. My 
research efforts have contributed to further elucidating how Y. pestis uses Rab proteins within 
macrophages in order to establish a permissive intracellular environment and create a spacious 
YCV. I have identified eight Rab GTPases required for Y. pestis intracellular survival. Thus far five 
Rab proteins, Rab1b, 2b, 4a, 11b, and 20 have been found to be recruited to the YCV, while Rab13 
is not (Figure 5-1). Manipulation of vesicular trafficking and Rab GTPases localization is likely how 
Y. pestis survives and replicates within macrophages, providing a niche that ultimately contributes 
to avoiding destruction by neutrophils prior to upregulating expression of the T3SS.  
To better understand how neutrophils are also subverted by Y. pestis in order to survive and 
maintain an early non-inflammatory host environment as seen during pneumonic plague, I infected 
human neutrophils with Y. pestis and determined whether granule and LTB4 release was inhibited. 
I demonstrated that exocytosis of all four neutrophil granule/vesicle types are inhibited through a 
T3SS dependent manner. I also identified previously unknown contributions of YpkA and YopJ 
regarding inhibition of neutrophil degranulation. Working cooperatively, YopE with YopH or YopJ, 
or YopH with YpkA, YopE, YopJ, and potentially with YopK, inhibit the release of specific and 
azurophilic granules. Two of the three signaling pathways involved in neutrophil degranulation must 
be inhibited by the Yop effectors in order for azurophilic and specific granule exocytosis to be 
inhibited (Figure 5-2). As observed for degranulation, the Ysc T3SS is also able to inhibit release 
of LTB4 from neutrophils through the individual actions of YpkA, YopE, YopH, YopJ, and YopT. The 
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five Yop effector proteins function by disrupting actin cytoskeletal rearrangement or TAK1/ERK 
signaling (Figure 5-3).  
My efforts to better understand how Y. pestis survives within macrophages and subverts 
neutrophil antimicrobial responses, have guided me to three broad future questions that I think are 
important for better understanding what occurs during Y. pestis infection. The first question is: 
Mechanistically, how does Y. pestis modulate host vesicular trafficking to escape degradation and 
establish a replicative niche? The second question is: How does Y. pestis inhibit the release of 
neutrophil antimicrobial products mechanistically? Finally, the third question is: Are the neutrophil 
responses to Y. pestis infection the same between murine neutrophils and human neutrophils? I 
have made additional observations and proposed future directions for this work, which are detailed 
in the subsequent paragraphs.  
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Figure 5-1: Rab GTPases localize to the YCV. 
In order for Y. pestis to avoid degradation by macrophages, the YCV does not fuse to lysosomes 
and instead associates with markers of autophagy before replicating and lysining out of the cell. 
Many pathogens modulate Rab GTPases to alter pathogen containing vacuole trafficking events to 
avoid degradation. Y. pestis similarly uses Rab GTPases to avoid lysosomal degradation and to 
enter into a replicative niche. Y. pestis localizes with Rab1b, 2b, 4a, 11b and 20. While Rab1b and 
Rab4a no longer associate at late time points, Rab2b, 11b, and 20 remain to 10 h post infection.   
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Figure 5-2: Inhibition of neutrophil granule release by Y. pestis.  
Granule release from neutrophils are regulated by three different signaling nodes, the MAPK 
cascade, Rac/Rho signaling, and the focal adhesion complex/Ca2+ flux. Yersinia pestis injects 
neutrophils with seven bacterial effector proteins that interact with host proteins to inhibit signaling 
from occurring. Inhibition of two of the three signaling nodes important for granule release by 
YpkA/YopE/YopT, YopH, and YopJ prohibits neutrophils from exocytosing granules in response to 
Y. pestis infection. During infection with WT Y. pestis, all three pathway nodes would be inhibited 
for maximal suppression of neutrophil granule release.   
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Figure 5-3: Inhibition of LTB4 production by T3SS effector proteins. 
LTB4 production in neutrophils is regulated by multiple signaling pathways, the MAPK cascade, 
Ca2+ flux, and actin cytoskeleton rearrangement. Yersinia pestis injects seven bacterial effector 
proteins into neutrophil cytosol that interact with host proteins to inhibit signaling from occurring. 
Inhibition any one of the three signaling nodes by YpkA, YopE, YopT, YopH, or YopJ prohibits 
neutrophils from producing LTB4 in response to Y. pestis infection. During infection with WT Y. 
pestis, all three pathway nodes would be inhibited for maximal suppression of LTB4 production 
and release. 
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ADDITIONAL OBSERVATIONS AND QUESTIONS 
5.1 How does Y. pestis survive and replicate within macrophages? 
My research efforts have identified additional Rab proteins targeted by Y. pestis to establish 
a permissive intracellular environment not previously identified by the Connor et al. [119]. However, 
knowing that Rab GTPases are important for Y. pestis intracellular survival, and which Rabs co-
localized to the YCV, only provides a partial story of what is happening within macrophages during 
infection. Further work is needed to fully understand how Y. pestis survives and replicates in 
macrophages. In the discussion of Chapter 3, I proposed several experiments to better understand 
the roles of Rab2b, 13, and 20 in Y. pestis intracellular survival. The following sections will instead 
focus on testing two potential hypotheses that may be used by Y. pestis to generate the YCV.  
5.1.1 Hypothesis 1: Y. pestis encodes effector proteins to modulate Rab protein trafficking. 
Eight macrophage Rab proteins were identified as important for Y. pestis intracellular 
survival. Other pathogens, such as L. pneumophila or S. typhimirium utilize bacterial encoded 
effector proteins that directly targets and modulates Rab protein activity to change the localization 
[328-334]. Rab1b, Rab4a, Rab11b, Rab2b and Rab20 are recruited to the YCV during infection of 
macrophages, this raises the possibility that Y. pestis, similar to other intracellular pathogens, 
encodes effector proteins that are delivered into the host cell to actively target and modify these 
Rab GTPases, ultimately leading to recruitment of them to the YCV. To date, conventional bacterial 
mutagenesis loss of function approaches have not yielded any potential bacterial effector proteins 
from Y. pestis required for YCV biogenesis, or that interact with Rab proteins (or Rab interacting 
partners), which could be explained by functional redundancy (i.e., Y. pestis encodes more than 
one effector protein that is sufficient to generate the YCV). However, now that I have identified Rab 
proteins required for the YCV biogenesis, we can use a host-directed approach to identify bacterial 
proteins that interact with these Rab proteins, bypassing complications of functional redundancy. 
Specifically, to identify potential bacterial effector proteins interacting with the Rab proteins known 
to be important for Y. pestis intracellular survival, I would use a protein interaction discovery tool, 
termed BioID [335, 336]. BioID is a useful tool for labeling interacting proteins, as it is an enzyme 
that biotinylates proteins within close proximity to the tagged protein of interest, in this case our 
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Rab GTPases of interest [335]. Fusion of BioID to individual Rab proteins could then be 
overexpressed in RAW264.7 cells. Upon transfection of the Rab-BioID construct, cells would then 
be infected with Y. pestis to deliver potential bacterial effector proteins into the macrophages. 
Proteins (bacterial and host) in close proximity to the Rab-BioID complex would be biotinylated. 
Lysis of the macrophages followed by pull down with streptavidin, would purify the biotin labeled 
proteins that were in proximity to the Rab protein. Using MS/MS on the purified proteins would allow 
for identification of the tagged proteins. The BioID method is advantageous for two reasons: 1) 
Proteins in close proximity are marked, even if the interaction is transient, allowing for identification 
of interactions otherwise missed due to time constrained assays; 2) BioID does not require tight 
interacts between the host protein and potential bacterial protein that might be disrupted through 
traditional pull down assays. While a temporal aspect can be incorporated to finely dissect event 
timelines, all interactions, whether early or late in the infection process, can be identified using 
BioID and harvesting at a later time post-infection. BioID results could be further validated by 
conventional in vitro biochemical protein-protein interaction assays and characterization of the YCV 
biogenesis process during infection with bacterial mutants in potential Rab interacting proteins. 
One caveat to this approach is that if Y. pestis effector proteins do not directly interact with 
the Rab protein of interest tagged to BioID, but instead with a host Rab interacting protein, those 
interactions would not be identified. If the BioID approach fails to identify bacterial proteins 
interacting with the Rab proteins of interest, an alternative approach would be to determine if 
specific Rab interacting partners are required for YCV biogenesis and/or intracellular survival. This 
could be accomplished using RNAi for these proteins as I have shown for the individual Rab 
proteins. If RNAi identifies specific Rab interacting partners required for Y. pestis intracellular 
survival, BioID using those Rab interacting partners as bait could be used to identify potential 
bacterial proteins that they are interacting with.  
5.1.2 Hypothesis 2: Y. pestis binds to a specific receptor to avoid phagosome maturation. 
While bacterial effector proteins mediate phagosome maturation during infection with other 
bacteria, it is possible that Y. pestis may not encode effector proteins to alter vesicular trafficking 
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through targeting of Rab proteins. Alternatively, ligation to a receptor, or manipulation of receptor 
adaptors could dictate intracellular trafficking events. For example, Chlamydia pneumoniae 
interacts with the epidermal growth factor receptor (EGFR) to subvert lysosomal degradation and 
directly enter into the recycling pathway [337]. Since we have shown that the YCV is remodeled to 
resemble a recycling endosome, this raises the possibility that Y. pestis could use a receptor 
mediated mechanism similar to C. pneumoniae to enter the recycling pathway. However, what 
receptor mediates Y. pestis phagocytosis by macrophages is unclear. 
Receptor ligation is not a novel concept in Y. pestis biology, several receptors have been 
identified that are expressed by innate immune cells and bind to different surface expressed 
antigens on Y. pestis. Formyl peptide receptor 1 (FPR1) is the most recent innate immune cell 
receptor shown to bind to Y. pestis [338]. Binding to FPR1 via T3SS tip protein LcrV, enhances 
delivery of Yop effector proteins into the host cell cytosol, and is detrimental to the innate immune 
cells due to increased targeting efficiency by the T3SS [338]. However the T3SS is not expressed 
upon transmission from the flea vector into the mammalian host, when Y. pestis is first interacting 
with macrophages and bacteria lacking the pCD1 plasmid, which encodes the T3SS, are still able 
to generate a YCV and survive within macrophages [102]. Therefore, FPR1 ligation to LcrV is 
unlikely to mediate uptake of Y. pestis by macrophages or play a role in YCV biogenesis.  
Other known host receptors which bind to Y. pestis antigens expressed upon transmission 
from the flea vector are CD205 (DEC-205) and CD209 (SIGN-R1) [52, 339, 340]. CD205 and 
CD209 bind to Pla and the core of LPS, respectively, but whether CD205 ligation to Pla or CD209 
ligation to LPS impacts vesicular trafficking within macrophages is not known. Blocking either 
receptor diminishes phagocytosis of Y. pestis. However, only partially, indicating another receptor, 
or perhaps binding to multiple receptors dictates Y. pestis uptake by macrophages [339]. 
TLR4 is also an intriguing possibility as a potential receptor for mediating Y. pestis 
phagocytosis. TLR4 is endocytosed upon ligation to LPS and returned to the plasma membrane 
through the recycling pathway, similar to EGFR. Y. pestis is known to modulate TLR4 signaling, by 
changing LPS acylation and by inhibiting MyD88 signaling [49, 51, 301]. Interestingly, TLR4 can 
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traffic to different intracellular compartments, such as early endosomes, phagosomes, Rab11 
positive recycling vesicles, and multi-vesicular bodies depending on the signaling pathway 
activated (reviewed in [341]). Inhibition of TLR4 signaling, through disruption of adaptor protein 
recruitment modulates trafficking of TLR4 within cells [342, 343]. Interestingly, binding of E. coli by 
TLR4 induces not only signaling cascades, but phagocytosis specifically by ligation of LPS with 
TLR4 through the adaptor protein TRAM [343, 344]. In turn, TRAM interacts with Rab11 family of 
interacting proteins 2 (FIP2) [343]. Manipulation of TLR4 ligation to bacterial bound LPS and 
interaction with adaptor proteins presents a point where Y. pestis could exploit host cell signaling 
to its advantage. Both TLR4 and EGFR can be found in Rab11 positive endosomes for recycling 
back to the plasma membrane. Therefore, targeting of TLR4 (or EGFR) may allow pathogens to 
avoid phagolysosomal fusion. We do not clearly understand how Y. pestis induces uptake by 
macrophages, but because Y. pestis LPS is known to modify TLR4 signaling, it raises the possibility 
that binding to TLR4 may contribute to YCV biogenesis independent of direct bacterial effector 
recruitment. Knockdown of TLR4, EGFR, and other potential receptors (i.e CD205 and CD209), or 
TLR4 associated proteins (CD14 and MD-2) could be used to identify if Y. pestis is binding and 
being taken up through a receptor dependent pathway to modulate Y. pestis intracellular trafficking. 
Knockdown could be combined with other assays to evaluate whether fusion with lysosomes is 
impacted, or association with markers of autophagy and YCV expansion.  
5.2 How are neutrophil antimicrobial responses altered during Y. pestis infection? 
The data presented in Chapter 4 enhances our understanding of how Y. pestis inhibits 
release of neutrophil granules and LTB4 production. However, through my work studying neutrophil 
responses to Y. pestis, I have accumulated additional observations that have raised questions for 
further exploration. The following paragraphs discuss these questions and potential future 
directions of study to better understand Y. pestis-neutrophil interactions.  
5.2.1 Which host proteins do Yop effectors interact with in human neutrophils to inhibit signaling?  
Much of our current understanding of how Y. pestis Yop effector proteins impact host 
signaling pathways comes from studies using macrophages, with little verified in neutrophils. 
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Additionally, several Yops have been shown to modify multiple host proteins in vitro, but whether 
all or only one of these proteins is actually targeted in vivo is unclear. Moreover, many studies of 
Yop functions have used Y. pseudotuberculosis or Y. enterocolitica, not Y. pestis [226, 285]. 
Although the T3SS and Yop effector proteins are highly conserved between the three species, 
there are some known differences that could influence outcomes [303]. Cumulatively, little evidence 
has been published that directly demonstrates which host proteins are directly targeted by Yops 
during Y. pestis infection of neutrophils. Better understanding how Y. pestis disrupts host cell 
signaling could potentially assist in mapping neutrophil signaling pathways that may differ from 
macrophages. 
To specifically identify host proteins that are targeted by Y. pestis Yop effectors within 
neutrophils, I would use the BioID system described in Section 5.1.1. Briefly individual Yop effectors 
would be fused to BioID and complemented into Y. pestis lacking the WT copy of the Yop protein 
(a copy lacking a Yop effector could be transformed into Y. pestis to act as a negative control and 
YopH, known to interact with FAC proteins in neutrophils, would act as confirmation of assay 
viability). Human neutrophils would then be infected, cells lysed, and biotinylated proteins purified, 
and identified by MS/MS. Identifying all the potential interactions of Yop effectors with host proteins 
would be invaluable to understand how Y. pestis inhibits neutrophil responses.  
5.2.2 How does Y. pestis inhibit the synthesis of LTB4? 
Production and release of LTB4 by neutrophils is an important factor for mounting an 
effective inflammatory response against bacteria [201, 203]. Synthesis of LTB4 requires 1) 
activation of receptor signaling, 2) activation of Ca2+ flux and/or MAPKs, 3) liberation of arachidonic 
acid, 4) phosphorylation of 5-LO and/or association with Ca2+, 6) translocation of 5-LO to the 
nucleus/other membranous compartment, 7) association with accessory proteins (i.e. FLAP), and 
8) activity of LTA4H (Figure 1-3) [189, 191, 194, 195, 345]. While these steps are known to be 
important for LTB4 production, there remains aspects that are unknown. Translocation of 5-LO from 
the cytosol to a lipid membrane is a hallmark of active 5-LO. However, the mechanism that drives 
5-LO to translocate to membranes remains unclear. 5-LO associates with CLP and Grb2, two actin 
interacting proteins, and yet to date a direct role for the cytoskeleton in 5-LO translocation has not 
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been demonstrated. Additionally, phosphorylation by MAPKs and association with Ca2+ are also 
thought to be important for translocation to a membrane, but have not been fully elucidated. The 
lack of knowledge regarding what is critical for 5-LO translocation/activation presents an area for 
further exploration. My findings have pointed to the importance of ERK activation and a dynamic 
cytoskeleton, yet what remains unknown is which particular step(s) in the synthesis pathway is/are 
directly inhibited by the Yop effector proteins to inhibit production of LTB4?  
5-LO activity is regulated by the MAPK pathway, association with calcium, and requires 
translocation. All of these signal pathways are known targets of Yop effector proteins. Therefore, 
activation of 5-LO is likely a key regulatory point for inhibition of LTB4 production by Y. pestis. 
Previous studies have shown that ERK phosphorylation of 5-LO enhances activation and 
translocation [189, 191, 345, 346]. My work has shown that ERK phosphorylation is required for 
LTB4 production in response to Y. pestis. Thus, it is likely that inhibition of ERK phosphorylation by 
YopJ inhibits phosphorylation of 5-LO, and ultimately prevents translocation to a lipid membrane. 
To determine whether inhibition of ERK phosphorylation impairs phosphorylation of 5-LO during Y. 
pestis infection, western blotting could be performed using antibodies specific to un-phosphorylated 
and phosphorylated 5-LO during infection with Y. pestis T3(+), Y. pestis expressing YopJ only, or Y. 
pestis T3(-). Based on my results from Chapter 4, I expect that 5-LO phosphorylation will occur in 
cells infected with Y. pestis T3(-) but not those infected with Y. pestis T3(+)  or Y. pestis expressing 
only YopJ. Addition of ERK1/2 chemical inhibitor (U0126) to cells infected with Y. pestis T3(-) will 
be able to determine if this inhibition is ERK specific. Whether 5-Lo phosphorylation by ERK is 
required for translocation to the nuclear membrane/lipidosome is not clear, but microscopy studies 
to evaluate cellular localization of 5-LO in relation to FLAP, the nucleus, or lipidosomes could be 
used in infected cells to determine if Y. pestis inhibits this required step in LTB4 synthesis. 
While ERK mediated phosphorylation of 5-LO is important for 5-LO activation, LTB4 
production was also inhibited by Yop effector proteins that target cytoskeleton rearrangement, but 
independent of MAPK signaling. Translocation of 5-LO upon activation is known to occur, although 
no conclusive evidence as to how the translocation occurs has been shown. Currently, there are 
three factors which have been proposed to drive translocation of 5-LO, phosphorylation, 
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association with Ca2+, and movement via the actin cytoskeleton. The first two factors, 
phosphorylation and association with Ca2+ are thought to increase the affinity between 5-LO and 
phosphatidylethanolamine (PE) to drives 5-LO to membranous compartments rich in PE [191, 345]. 
Whether the increased affinity for PE is sufficient to drive translocation has not been determined. 
Moreover, whether both phosphorylation and association with Ca2+ are required, or if one or the 
other is sufficient, remains undetermined. A more likely scenario, is that active transport by the 
cytoskeleton assists in translocation and is enhanced by the increase in affinity for PE. The 
requirement for cytoskeleton rearrangement is supported by my finding that four Yop effectors 
which target the cytoskeleton can inhibit translocation, in addition to data showing 5-LO interacts 
with CLP and Grb2, actin binding proteins [186, 345]. Based on this information, I developed the 
hypothesis that Y. pestis inhibits LTB4 production by disrupting not only ERK phosphorylation, but 
also cytoskeletal rearrangement and Ca2+ flux, thereby preventing translocation of 5-LO from the 
cytosol to membranes rich in AA. To understand the importance of Ca2+ flux and the role of 
cytoskeletal rearrangement for 5-LO activity two different approaches would need to be 
implemented. The first approach would aim to understand the role of Yop effectors which target the 
actin cytoskeleton. To do this, I would use antibodies specific to 5-LO, FLAP, and stains specific to 
the nuclear membrane and lipidosomes in combination with phalloidin, which binds to the actin 
cytoskeleton. Using these markers, I would infect neutrophils with Y. pestis T3(+), Y. pestis 
independently expressing each of the four Yop effector proteins (YpkA, YopE, YopH, and YopT), 
or Y. pestis T3(-) with or without latrunculin A pre-treatment. I would then assess 5-LO co-
localization to FLAP/membrane compared to UT neutrophils as a negative control. I expect that 
infection with Y. pestis T3(-) would result in co-localization to FLAP/membrane. I also expect that 
WT Y. pestis would not result in co-localization, and a similar result for the four Yop effector protein 
infections, as well as T3(-) when latrunculin A is used as a pre-treatment. Results similar to those 
stated would confirm that translocation via the cytoskeleton is important for 5-LO activity. To further 
define the cytoskeletal signaling pathway important for 5-LO translocation, I would use inhibitors 
specific for Rac or RhoA in place of latrunculin A. 
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The second approach would aim to delineate the role of Ca2+ in translocation and activity 
of 5-LO during Y. pestis infection, focusing specifically on YopH. YopH inhibits signaling through 
the FAC and in so doing, inhibits Ca2+ flux in neutrophils. Therefore, it is likely that inhibition of Ca2+ 
flux by YopH impacts LTB4 production as well. For this approach, cells would be infected with Y. 
pestis T3(+),Y. pestis T3(-), or Y. pestis expressing only YopH and treated with calcium ionophores 
or calcium chelators. Localization of 5-LO would be assessed as described above, in addition to 
collection of supernatants to determine LTB4 production, described in the methods section. If the 
activity of YopH on Ca2+ flux is responsible for inhibit translocation of 5-LO, then it would be 
expected that the simple addition of a Ca2+ chelator during Y. pestis T3(-) infection would cause 5-
LO not to translocate to FLAP, and LTB4 not to be produced. Conversely, utilization of a Ca2+ 
ionophore concomitantly with Y. pestis T3(+) or Y. pestis expressing only YopH would result in 
translocation of 5-LO to FLAP and production of LTB4. Together, these studies will identify the 
specific molecular mechanisms used by Y. pestis to inhibit LTB4 synthesis. 
5.2.3 What impact does YopJ inhibition of p38 phosphorylation have on neutrophil responses? 
While the MAPK pathway is required for production of LTB4, many other neutrophil 
antimicrobial responses also rely upon the MAPK pathway for activation. Some antimicrobial 
responses that depend on MAPK signaling include: production of the respiratory burst, granule 
release, and cytokine production [159, 216, 313, 347]. Signaling through the MAPK pathway is also 
not a simple, linear cascade, but rather, a complex, multi-branched, differentially activated network 
that works in a coordinated way to enact specific responses in a regulated manner [216, 313, 348]. 
I showed that the effector protein YopJ encoded by Y. pestis is sufficient to inhibit ERK signaling 
and block production of LTB4. Furthermore, I have also shown that p38 is also blocked by the 
activities of Y. pestis, but that inhibition of p38 phosphorylation was not required for inhibition of 
LTB4 production (Figure 4-8). Phosphorylation of p38 is blocked by the action of YopJ (Figure 5-4), 
however the benefit of blocking p38 phosphorylation in neutrophils to Y. pestis has not been 
elucidated to date. Signaling through p38 is essential to activation of the respiratory burst and 
granule release [154, 159, 325, 347, 349], two neutrophil antimicrobial responses inhibited by the 
Y. pestis T3SS [166]. The direct inhibition of p38 was not demonstrated as the key factor regulating 
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these responses to Y. pestis infection, and the question remains whether YopJ inhibition of p38 
phosphorylation is directly responsible for inhibition of the respiratory burst and degranulation. To 
determine whether Y. pestis, and specifically YopJ inhibit p38 phosphorylation in neutrophils to 
directly inhibit the respiratory burst and degranulation, I would use a combination of chemical 
inhibitors and Y. pestis strains to infect neutrophils and then monitor production of ROS and release 
of granules. Briefly, I would pretreat neutrophils with or without an inhibitor of p38 and subsequently 
leave cells untreated or infect with either Y. pestis T3(+), Y. pestis T3(-), or Y. pestis only expressing 
YopJ. I would confirm inhibition of p38 is occurring via Western blot, then I would assay granule 
release as outlined in the methods section, or measure ROS production with a luminol assay. If 
inhibition of p38 phosphorylation is required to inhibit these processes, I expect to observe reduced 
ROS and granule release by Y. pestis T3(-) infected neutrophils in the presence of the p38 inhibitor. 
However, especially for degranulation two of three pathways may need to be inhibited by Yop 
effector proteins in order to fully suppress granule release. Therefore, inhibition of degranulation 
may only be observed when a Y. pestis strain expressing only YopE and YopJ, or YopH and YopJ 
is used. If addition of the p38 inhibitor does not inhibit ROS or degranulation, then a second inhibitor 
of Rac2 or Ca2+ flux may need to be used. 
 
Figure 5-4: YopJ inhibits p38 phosphorylation. 
Human neutrophils (8x106) were infected with Y. pestis KIM1001 with or without the pCD1 plasmid 
encoding the T3SS (T3+ or T3-, respectively), or expressing only yopJ (+J); MOI = 100. (A) 
Representative western blot with mean relative expression of phosphorylated or un-phosphorylated 
p38 during infection with indicated strains. (B) Mean relative expression of phosphorylated p38 
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during infection with indicated Y. pestis strains. Y. pestis KIM1001 = T3+; KIM1001 T3(-) = T3-; 
KIM1001 expressing only yopJ =  +J; Uninfected = UT. Mean ±SEM from 3 biologically independent 
experiments. One-way ANOVA with Sidak’s post-hoc; ns= not significant, ****, P<0.0001. 
5.2.4 Does Y. pestis inhibit release of NETs by neutrophils? 
In addition to the antimicrobial mechanisms I have previously discussed, neutrophils can 
also restrict bacterial growth by limiting the availability of metals through release of calprotectin, to 
sequester Zn, Mn, and Fe from pathogens [350]. This is part of the host response to infection 
termed nutritional immunity. Mechanisms used by Y. pestis to overcome nutritional immunity are 
key to infection and understanding these mechanisms is of great interest in our lab. Calprotectin 
composes ~40% of the cytosolic protein in neutrophils, and is normally released in response to 
infection independent of granule release [157]. 
Having observed that Y. pestis actively inhibits other exocytic processed in neutrophils (i.e. 
degranulation) I also predicted that that Y. pestis inhibits release of calprotectin by neutrophils. To 
test this hypothesis human neutrophils were treated with Y. pestis KIM1001 with or without the 
T3SS (T3+ or T3-), E. coli, PMA (positive control), or co-treated with Y. pestis expressing the T3SS 
(T3+) and PMA for 30 min, 1 h, or 3h. Release of calprotectin into the supernatant was measured 
by ELISA (Figure5-5). At 30 min post-infection, calprotectin was not detected in any of the samples 
collected. However, by 1 h post-infection, PMA-treated neutrophils began to release calprotectin 
slightly over that measured for UT, while the other treatments remained below UT levels. By 3 h 
post-infection, PMA treatment induced release of calprotectin to significantly higher levels (p; 
>0.001). Intriguingly, co-treatment with Y. pestis T3(-) and PMA did not result in increased 
calprotectin release similar to that seen for PMA alone at 3 h PI (Figure 5-5A). These data indicate 
that at least in vitro, Y. pestis is able to inhibit calprotectin release by human neutrophils. Infection 
with Y. pestis T3(-) by 3 h post infection also did not result in release of calprotectin over that 
observed for UT, and the level of calprotectin is similar to Y. pestis T3(+) at 3 h post infection. Taken 
together, this data indicated release of calprotectin from human neutrophils is being inhibited by Y. 
pestis in a T3SS independent manner. 
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Figure 5-5: Y. pestis inhibits release of calprotectin from human neutrophils. 
Human neutrophils (4x106) were infected with Y. pestis KIM1001 with or without the pCD1 plasmid 
encoding the T3SS (T3+ or T3-, respectively), E. coli, or treated with PMA and infected with Y. 
pestis at the same time; MOI=100. (A) Release of Calprotectin was measured after 30 min, 1 h, or 
3h after infection in supernatant. (B) Calprotectin in supernatant from PMA post treated with Y. 
pestis for 3 h or supernatant from neutrophils that were mixed with an equivalent number of Y. 
pestis or E. coli as was in the original cell infection (3 h). Mean ± SEM from 3 biologically 
independent experiments. One-way ANOVA with Dunnett’s post hoc test to UT or PMA. **, P<0.01; 
****, P<0.0001.  
 
The absence of calprotectin in the culture supernatant in both Y. pestis T3(+) and T3(-) 
indicated that calprotectin levels are controlled by a T3SS independent mechanism. One possible 
mechanism may be that the bacterium does not inhibit release, but degrades calprotectin once 
released. Y. pestis encodes several proteases that may be contributing to degradation of 
calprotectin. In order to test whether Y. pestis uses a protease to degrade calprotectin, supernatant 
from the PMA 3 h treated neutrophils was incubated at 37°C for 3 h, either without bacteria, with 
an equivalent amount of Y. pestis (T3(+) or T3(-)) or with E. coli to the bacteria to volume ratio initially 
incubated with neutrophils. Incubation of PMA supernatant with Y. pestis T3(+), Y. pestis T3(-), or E. 
coli did not result in a reduction of calprotectin present (Figure 5-5B). This observation suggests 
that Y. pestis does not degrade calprotectin released into the supernatant through the activity of a 
protease, and instead suggests that calprotectin release is inhibited by Y. pestis.  
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The leading mechanism proposed for calprotectin release is through a mechanism referred 
to as Neutrophil extracellular trap (NET) release or NETosis [157, 350, 351]. NETosis is a process 
where decondensed DNA is extruded by neutrophils, and is thought to be an active process to 
“trap” pathogens in order to limit their dissemination [178, 278]. NETosis occurs when granule 
proteins, such as neutrophil elastase (NE) are released into the cytosol through activation of PAD4, 
and subsequently enters into the nucleus [175]. NE degrades histones to de-condense the genetic 
material and allows for DNA extrusion into the extracellular matrix. In addition to DNA, these NETs 
are decorated with granule and cytosolic proteins such as elastase, myeloperoxidase, and 
calprotectin, which can directly kill or metabolically starve the pathogen [174].  
While previous studies have reported that Y. enterocolitica and pseudotuberculosis 
stimulate NET release due to expression of the bacterial adhesin protein YadA [352], YadA was 
lost during divergence of Y. pestis from Y. pseudotuberculosis and the degree of NETosis in 
response to Y. pestis has not been clearly evaluated. However, my preliminary data demonstrating 
an absence of calprotectin release in response to Y. pestis strongly suggests that Y. pestis inhibits 
NETosis. To test this idea, I would adhere neutrophils to coverslips and infect the cells with Y. 
pestis or the enteric Yersinia. I would then use antibodies for calprotectin, neutrophil elastase, and 
myeloperoxidase to measure NET release. If Y. pestis inhibits NETosis, I expect to observe 
diminished levels of CP, NE, and MP around neutrophils infected with Y. pestis compared to the 
enteric Yersinia and the positive control, PMA. However, if Y. pestis does not suppress NETosis, 
this would indicate that calprotectin is being released by a mechanism independent of NETosis. 
5.2.5 Does the exosome profile released by neutrophils change upon infection with Y. pestis? 
My data strongly supports that Y. pestis is capable of inhibiting exocytic pathways by 
human neutrophils, including the release of granules and calprotectin. Exosomes are small vesicles 
released by cells through fusion of multivesicular bodies to the plasma membrane and can contain 
proteins, RNAs, and lipids [353-355]. These vesicles have increasingly been the topic of host cell 
communication studies [193, 194, 356]. Mounting evidence shows that exosomes are released with 
contents to relay messages to other cells nearby, or even ones far away [353, 356]. Incorporating 
DNA, RNA, proteins, or lipids within a membrane bound envelope increases molecular stability and 
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allows for enhanced traversing of distances to relay information that would otherwise quickly be 
degraded in the extracellular milieu [193, 194, 354]. Release of exosomes is dependent on the 
actin cytoskeleton [357], a known target of Yop effector proteins [72, 74-76, 358]. However, since 
Y. pestis has been shown to inhibit other arms of exocytosis, it is intriguing to consider that Y. pestis 
may also inhibit the release of exosomes to curtail innate immune cell responses to infection.  
The first question that would need to be answered to test this hypothesis is whether Y. 
pestis completely inhibits exosome release similar to degranulation? To answer this question, I 
would infect human neutrophils with M. bovis as a positive control [359], Y. pestis T3(+) or Y. pestis 
T3(-), isolate exosomes using ultracentrifugation, and quantify the amount of exosomes released 
by each sample using an ELISA. If Y. pestis inhibits exosome release, I would expect fewer 
exosomes from neutrophils infected with Y. pestis T3(+) compared to M. bovis. Moreover, if 
exosome inhibition is dependent on the T3SS, then the concentration of Y. pestis T3(-) exosomes 
would be significantly greater than Y. pestis T3(+)  
The second question that would need to be explored is if Y. pestis infection modifies 
exosome content (this could occur in addition to inhibition of release or separately). To determine 
if the exosome content differs between UT neutrophils, neutrophils infected with a non-pathogenic 
bacteria such as E. coli, and neutrophils infected with Y. pestis, I would infect human neutrophils 
and then isolate exosomes as described above. I would standardize the number of exosomes 
analyzed and then use lipidomics, proteomics, and transcriptomics to analyze differences between 
the samples. If differences are observed, then the impact of these exosomes on innate immune 
cell function could be explored. This study could be further extended to in vivo Y. pestis infection 
of mice, where exosomes could be isolated from Y. pestis T3(+) and T3(-) infected mouse tissues, 
such as the lungs or lymph nodes, If the exosome profile is different between T3(+) and T3(-) infected 
mice, it would be interesting to determine if exosomes from the Y. pestis T3(-) infected mice could 
be transferred to naïve mice to induce control of the Y. pestis T3(+) infection.  
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5.3 What is the impact of LTB4 signaling on plague? 
5.3.1 Does exogenous addition of LTB4 enhance the degradative capacity of innate immune 
cells?  
LTB4 is critical to controlling infection caused by many pathogens [203, 208-210, 360]. The 
importance of LTB4 in controlling infection is due to the ability of LTB4 to stimulate enhanced 
phagocytosis, improved microbial killing, and trafficking of innate immune cells to the site of 
infection, via establishment of a chemotactic gradient [203, 206]. Exogenous addition of LTB4 
enhances the innate immune response and can foster immune cell mediated clearance of infection 
[198]. Since I have shown that Y. pestis actively inhibits LTB4 release from human neutrophils, and 
LTB4 influences immune cell antimicrobial responses, I hypothesize that exogenous addition of 
LTB4 to innate immune cells (i.e. neutrophils and macrophages) would enhance killing of Y. pestis 
in vitro. To test this, human macrophages and neutrophils would be isolated and adhered to 
separate 96-well plates. I would add exogenous LTB4 (a range of concentrations) to the phagocytic 
cells either prior to or at the time of Y. pestis infection, and survival of Y. pestis would be monitored 
over time. The ability to kill Y. pestis would be compared to the cells which did not receive LTB4. 
Based on the ability of LTB4 to enhance the antimicrobial activities of phagocytic cells, I would 
expect that the macrophages and neutrophils treated with LTB4 and infected with Y. pestis would 
show an enhanced killing of Y. pestis, over that observed for cells which were not treated with LTB4. 
To verify the activity is attributable to LTB4, chemical inhibitors of BLT1, the primary receptor could 
be used to inhibit signaling through the primary receptor, or inhibit BLT1 signaling using blocking 
antibodies. 
5.3.2 Could administration of LTB4 enhance host resistance to pneumonic plague?  
Although there is much that can be learned from in vitro studies with immune cells, it is 
impossible to fully model the complex and dynamic interactions that occur between multiple cell 
types as occurs in vivo. The murine model of plague is the most commonly used laboratory model 
used to study Y. pestis virulence, and disease in mice recapitulates many of the hallmarks of plague 
observed in human, included delayed inflammation, infection of draining lymph nodes, bubo 
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formation, and necrosis of tissue [85, 110]. Therefore, while I have shown inhibition of neutrophil 
responses in vitro, in the future it would be desirable to translate these studies into an in vivo model 
like the mouse to better understand the consequences of these interactions in the context of the 
entire immune system.  
The inhibition of LTB4 by Y pestis in vitro suggests LTB4 should not be released during in 
vivo infection either. However, neutrophils are not the only cell type capable of producing LTB4, 
other immune cells, such as macrophages and mast cells are also capable of producing LTB4, 
which many release LTB4 in vivo [282, 322]. To ascertain if LTB4 is produced during in vivo infection, 
mice were infected via intranasal instillation during a pilot study. Briefly Y. pestis with or without the 
T3SS (T3+ or T3-, respectively), or the negative control, PBS, was instilled into the mouse lungs. 
BALF was collected at 12 h PI, concentrated using a C18 column, re-suspended in H2O, and LTB4 
was measured. Infection of mice via intranasal instillation of either Y. pestis strain did not result in 
a significant increase in LTB4 released (Figure 5-6C). Together, these data suggest Y. pestis 
infection does not release LTB4, but additional time points should be examined to completely 
characterize the LTB4 response during pneumonic plague. A caveat to this data is that while LTB4 
does not appear to be released upon infection of mice with Y. pestis, infection with a pathogen 
known to induce release of LTB4 in the lungs, such as Klebsiella pneumoniae, would provide further 
evidence that LTB4 can be released, but that Y. pestis does not stimulate release or actively inhibits 
LTB4 release [198, 203]. 
However, these preliminary data support the hypothesis that inhibition of the LTB4 
mediated response contributes to the non-inflammatory environment associated with early plague. 
To understand whether exogenous addition of LTB4 increases resistance to WT Y. pestis during in 
vivo infection, I would infect mice with WT Y. pestis that have received exogenous LTB4. (dose and 
timing of administration could be titrated), monitoring bacterial proliferation and host survival as a 
measurement of efficacy. If inhibition of LTB4 contributes to the non-inflammatory environment 
associated with pneumonic plague, I expect that the mice treated with LTB4 would have less Y. 
pestis CFU counts and would survive longer than the mice that were not treated with LTB4. One 
caveat to this approach is that LTB4 is highly inflammatory. Treatment of mouse lungs with LTB4 
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could cause detrimental inflammation over that beneficial to clearing the Y. pestis infection, which 
could lead to damage of the lung tissue, pneumonia, and death. Careful titration would be needed 
to determine an effective dose, that doesn’t stimulate deleterious effects, within the mouse lungs. 
5.4 Do murine neutrophils release LTB4 in response to Y. pestis? 
While mice are widely used to model human infection, it is widely recognized that human 
and mouse neutrophils differ in their responses to bacteria, and I described some of these 
differences in Chapter 1. Data published near the when I published my data on degranulation 
indicates that Y. pestis is also able to inhibit degranulation in murine neutrophils [361]. However, 
the LTB4 response by murine neutrophils to Y. pestis has not been explored. Therefore, to begin 
to answer this question, bone marrow derived neutrophils (BMNs) from C57Bl/6 mice were isolated 
and infected with Y. pestis KIM1001 with or without the T3SS (T3+ and T3-, respectively). After 30 
min of infection, supernatant was collected and release of LTB4 was measured (Figure 5-6). As 
observed for human neutrophils, infection with Y. pestis T3(+) did not result in significant LTB4 
secretion over untreated BMNs. Surprisingly, BMNs infected with Y. pestis T3(-) also did not release 
LTB4. This lack of LTB4 production was likely not due to the maturity of BMNs compared to 
peripheral neutrophils, since infection with E. coli resulted in production of LTB4 (Figure 5-6A). 
These findings with murine BMNs are in contrast to my previous studies with human neutrophils, 
and raise interesting questions about potential differences in LTB4 signaling between mouse and 
human neutrophils that should be explored further. 
Generally, mice produce a more toleragenic response to infection than humans, which may 
be why LTB4, an inflammatory mediator, is released by human neutrophils and not murine 
neutrophils in response to Y. pestis [218]. The lack of a LTB4 response in murine BMNs compared 
to human neutrophils implies a difference exists in the host cell receptor recognition or downstream 
signaling from the receptor. For Y. pestis infection specifically, several differences between human 
and murine receptors have previously been identified, such as recognition of Y. pestis LPS [43, 50, 
338]. Production of LTB4 is dependent on signaling from receptors to the MAPK pathway and Ca2+ 
flux. Therefore, to better understand how murine neutrophils respond to Y. pestis infection versus 
human neutrophils, I would begin by looking at whether signaling through the MAPK pathway is 
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occurring in BMNs similar to what I have observed for human neutrophils (i.e. Y. pestis T3(-) 
stimulates phosphorylation of ERK and p38). I would also assess the role of Ca2+ flux in murine 
and human neutrophils and the impact on production of LTB4, to determine if the pathway is 
functioning in a similar manner in both cell types. To do this, I would use a Ca2+ ionophore to flood 
the neutrophils and assay LTB4 production. Subsequently, to understand transcriptional differences 
occurring between the human and murine neutrophils in response to Y. pestis infection, I would 
perform RNAseq on highly purified neutrophils from humans and mice to directly compare the 
differential responses enacted by each cell type to Y. pestis infection. While the mechanisms may 
differ, it is important to stress that Y. pestis is able to evade LTB4 synthesis by both murine and 
human neutrophils. The ability to evade LTB4 synthesis supports my central hypothesis that 
inhibition of the normal LTB4 response to infection contributes to the ability of Y. pestis to establish 
a non-inflammatory environment. 
These preliminary data indicate that murine neutrophils are unable to mount a LTB4 
response to Y. pestis, which also raises the question of whether this is specific for Y. pestis, or 
applies to the enteric Yersinia pathogens. To begin to explore this question, I infected BMNs with 
Y. pseudotuberculosis and Y. enterocolitica and compared the LTB4 response to Y. pestis or E. coli 
(Figure 5-6B). Like Y. pestis, infection with Y. pseudotuberculosis did not result in increased release 
of LTB4 from the BMNs. However, infection with Y. enterocolitica did cause an increase in LTB4 
release over UT, although not to the level E. coli induced. To determine whether Y. pestis and Y. 
pseudotuberculosis actively inhibit release of LTB4 from BMNs, or if release is simply not 
stimulated, neutrophils were co-infected with E. coli and each Yersinia species expressing the 
T3SS (+/Ec). Co-infection of BMNs released LTB4 to a similar level as that observed for E. coli 
alone, suggesting Y. pestis and Y. pseudotuberculosis do not actively inhibit release of LTB4 from 
BMNs, but rather they do not stimulate release (Figure 5-6B). 
While Y. pestis and Y. pseudotuberculosis do not trigger release of LTB4, Y. enterocolitica 
and E. coli do trigger release from mouse neutrophils. Some factor seems to have been lost or 
gained during the divergence of Y. pseudotuberculosis and Y. enterocolitica from their common 
ancestor, that is responsible for the difference in LTB4 response observed between human and 
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mouse neutrophils. To understand what factor is different between Y. pseudotuberculosis and Y. 
enterocolitica a genomic analysis between the two species could be performed. Alternatively, a 
TnSeq library of Y. enterocolitica could be used to infect mouse bone marrow neutrophils in a high 
throughput screen to determine what is triggering LTB4 release. The hits could be compared back 
to Y. pseudotuberculosis and Y. pestis to verify lack of expression or modification upon divergence 
from Y. enterocolitica.  
 
Figure 5-6: LTB4 is not release from mouse phagocytes. 
(A) Bone marrow derived mouse neutrophils (1x106) were infected with Y. pestis KIM1001 or CO92, 
with or without the pCD1 plasmid encoding the T3SS (T3+ or T3-, respectively), or E. coli (Ec) 
MOI=100. Release of LTB4 was measured after 30 min of infection in supernatant. (B) Bone marrow 
derived mouse neutrophils (1x106) were infected with Y. pestis KIM1001 or CO92, Y. 
pseudotuberculosis, or Y. enterocolitica with or without the pCD1 plasmid encoding the T3SS 
(Y.p+, Y.p-, Y.ps+, Y.ps-, Y.e+, or Y.e- , respectively), or E. coli (Ec) alone or mixed 1:1 with the 
indicated Yersinia strain; final MOI=100, except for E. coli alone at MOI=50 and release of LTB4 
was measured 30 min after infection in the supernatant. Mean ± SEM from 2-9 biologically 
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independent experiments. (C) LTB4 in BALF from C57Bl6 mice were infected with fully virulent Y. 
pestis or lacking the pCD1 plasmid, T3+ and T3-, respectively. At 12 h post-infection, BALF was 
collected and LTB4 was concentrated using a C4 column. Mean ± SEM from 3 mice for each 
sample.  
CONCLUSIONS 
Yersinia pestis has masterfully adapted to subverting destruction by the innate immune 
system by subverting destruction mediated by both macrophages and neutrophils. The ways in 
which Y. pestis subverts antimicrobial responses utilized by the respective cell types differs greatly. 
However, many questions still remain regarding the exact mechanisms used by Y. pestis to subvert 
macrophage and neutrophil antimicrobial responses. The work presented here, in addition to the 
observations I have made, aim to address those questions. I have presented data demonstrating 
that Y. pestis relies on eight host Rab GTPases to survive and replicate within macrophages, and 
that five Rabs are co-localized to the YCV. The mechanistic roles these Rab GTPases play during 
Y. pestis intracellular survival are areas for continued research.  
Survival in macrophages provides Y. pestis the needed time to increase T3SS expression 
for survival outside of macrophages. Upon expression and exiting from macrophages, the T3SS 
inhibits further phagocytosis, and functions to combat antimicrobial defense mechanisms mounted 
by neutrophils. I demonstrated that Y. pestis inhibits release of all four neutrophil granule subtypes, 
and production of LTB4 through inhibition of the MAPK pathway. Furthermore, I have presented 
evidence that not only granule and LTB4 release are modified during Y. pestis infection, but also 
that other neutrophil responses may be modified as well. I also found that the ways in which human 
and mouse cells respond to Y. pestis infection are not always similar. Understanding whether a 
phenotype recapitulates in a mouse model and why differences between human cells and mouse 
cells occur will allow us to better understand how Y. pestis causes disease in different hosts. 
Together, the information obtained from this work and future studies will enable us to understand 
how Y. pestis maintains an early non-inflammatory host environment, hopefully leading us to a way 
in which Y. pestis infection of humans can be eliminated.  
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